Unnamed: 0.1,Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
26000,26000,,,5307338,[],CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
26001,26001,,,5307339,[],CHEMBL1694346,Antibacterial activity against Escherichia coli ATCC 25922 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,Activity,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,1.0
26002,26002,,,5307340,[],CHEMBL1694347,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
26003,26003,,,5307341,[],CHEMBL1694348,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,2.0
26004,26004,,,5307342,[],CHEMBL1694527,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
26005,26005,,,5307343,[],CHEMBL1694528,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
26006,26006,,,5307344,[],CHEMBL1694624,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,16.0
26007,26007,,,5307345,[],CHEMBL1694625,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
26008,26008,,,5307346,[],CHEMBL1694626,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
26009,26009,,,5307347,[],CHEMBL1694627,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,500.0
26010,26010,,,5307348,[],CHEMBL1694628,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,64.0
26011,26011,,,5307349,[],CHEMBL1694629,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
26012,26012,,,5307350,[],CHEMBL1694630,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
26013,26013,,,5307351,[],CHEMBL1694631,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 harboring GyrA S83L mutant,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
26014,26014,,,5307352,[],CHEMBL1694632,Ratio of mutant prevention concentration to MIC for qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
26015,26015,,,5307353,[],CHEMBL1694633,Ratio of mutant prevention concentration to MIC for qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
26016,26016,,,5307354,[],CHEMBL1694634,Ratio of mutant prevention concentration to MIC for qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
26017,26017,,,5307355,[],CHEMBL1694635,Antibacterial activity against Escherichia coli ATCC 25922 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1338560,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
26018,26018,,,5307356,[],CHEMBL1694636,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1338560,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
26019,26019,,,5307357,[],CHEMBL1694637,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1338560,=,1,1,=,,TIME,hr,,72.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,72.0
26020,26020,,,5307358,[],CHEMBL1694638,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1338560,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
26021,26021,,,5307359,[],CHEMBL1694639,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1338560,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
26022,26022,,,5307360,[],CHEMBL1694640,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1338560,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
26023,26023,,,5307361,[],CHEMBL1694641,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1338560,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
26024,26024,,,5307362,[],CHEMBL1694642,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1338560,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
26025,26025,,,5307363,[],CHEMBL1694643,Antibacterial activity against Escherichia coli ATCC 25922 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26026,26026,,,5307364,[],CHEMBL1694644,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
26027,26027,,,5307365,[],CHEMBL1694646,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
26028,26028,,,5307366,[],CHEMBL1694647,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
26029,26029,,,5307367,[],CHEMBL1694648,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
26030,26030,,,5307368,[],CHEMBL1694649,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
26031,26031,,,5307369,[],CHEMBL1694650,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
26032,26032,,,5307370,[],CHEMBL1694651,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
26033,26033,,,5307371,[],CHEMBL1694652,Ratio of mutant prevention concentration for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 to mutant prevention concentration for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
26034,26034,,,5307372,[],CHEMBL1694645,Ratio of mutant prevention concentration for Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 to mutant prevention concentration for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,2.0
26035,26035,,,5307373,[],CHEMBL1694653,Ratio of mutant prevention concentration for Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 to mutant prevention concentration for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
26036,26036,,,5307374,[],CHEMBL1694222,Ratio of mutant prevention concentration for Escherichia coli ATCC 25922 harboring GyrA S83L mutant to mutant prevention concentration for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,2.0
26037,26037,,,5307375,[],CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.015
26038,26038,,,5307376,[],CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.125
26039,26039,,,5307377,[],CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.125
26040,26040,,,5307378,[],CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
26041,26041,,,5307379,[],CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.125
26042,26042,,,5307380,[],CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
26043,26043,,,5307381,[],CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
26044,26044,,,5307382,[],CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
26045,26045,,,5307383,[],CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.004
26046,26046,,,5307384,[],CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
26047,26047,,,5307385,[],CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
26048,26048,,,5307386,[],CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
26049,26049,,,5307387,[],CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
26050,26050,,,5307388,[],CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
26051,26051,,,5307389,[],CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
26052,26052,,,5307390,[],CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
26053,26053,,,5308609,[],CHEMBL1691486,Antimicrobial activity against PMQR oqxAB positive Escherichia coli by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
26054,26054,,,5308610,[],CHEMBL1691487,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 mutant gene by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
26055,26055,,,5308611,[],CHEMBL1691488,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 and parC I80 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
26056,26056,,,5308612,[],CHEMBL1691489,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 and parC G84 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
26057,26057,,,5308613,[],CHEMBL1691490,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 and parC R84 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
26058,26058,,,5308614,[],CHEMBL1691491,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 N87 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
26059,26059,,,5308615,[],CHEMBL1691492,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 N87 and parC R80 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
26060,26060,,,5308616,[],CHEMBL1691493,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 N87 and parC I80 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
26061,26061,,,5308617,[],CHEMBL1691494,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 N87 and parC K84 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
26062,26062,,,5308618,[],CHEMBL1691495,Antimicrobial activity against PMQR oqxAB positive Escherichia coli harboring gyrA L83 N87 and parC I80 A84 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
26063,26063,,,5308619,[],CHEMBL1691496,Antimicrobial activity against PMQR qepA positive Escherichia coli harboring gyrA L83 N87 and parC I80 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
26064,26064,,,5308620,[],CHEMBL1691497,Antimicrobial activity against PMQR qepA positive Escherichia coli harboring gyrA L83 N87 and parC K84 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
26065,26065,,,5308621,[],CHEMBL1691498,Antimicrobial activity against PMQR oqxAB and qnrD positive Escherichia coli harboring gyrA L83 and parC R80 mutant genes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
26066,26066,,,5308622,[],CHEMBL1691499,Antimicrobial activity against PMQR oqxAB and qnrS1 positive Escherichia coli by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
26067,26067,,,5308623,[],CHEMBL1691500,"Antimicrobial activity against PMQR oqxAB, qnrB6 and aac(6')-Ib-cr positive Escherichia coli by CLSI agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
26068,26068,,,5308624,[],CHEMBL1691501,Antimicrobial activity against Escherichia coli C600 by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
26069,26069,,,5308625,[],CHEMBL1691502,Antimicrobial activity against oqxAB positive Escherichia coli C600 W281-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26070,26070,,,5308626,[],CHEMBL1691503,Antimicrobial activity against oqxAB positive Escherichia coli C600 W191-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26071,26071,,,5308627,[],CHEMBL1691504,Antimicrobial activity against oqxAB positive Escherichia coli C600 W322-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26072,26072,,,5308628,[],CHEMBL1691505,Antimicrobial activity against oqxAB positive Escherichia coli C600 W245-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26073,26073,,,5308629,[],CHEMBL1691506,Antimicrobial activity against oqxAB positive Escherichia coli C600 G262-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26074,26074,,,5308630,[],CHEMBL1691507,Antimicrobial activity against oqxAB positive Escherichia coli C600 G062-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26075,26075,,,5308631,[],CHEMBL1691508,Antimicrobial activity against oqxAB positive Escherichia coli C600 G375-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26076,26076,,,5308632,[],CHEMBL1691509,Antimicrobial activity against oqxAB positive Escherichia coli C600 X1B1-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26077,26077,,,5308633,[],CHEMBL1691510,Antimicrobial activity against oqxAB positive Escherichia coli C600 XT11-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26078,26078,,,5308634,[],CHEMBL1691511,Antimicrobial activity against oqxAB positive Escherichia coli C600 SW8-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26079,26079,,,5308635,[],CHEMBL1691512,"Antimicrobial activity against Escherichia coli C600 ST2-T transconjugant harboring oqxAB, qnrB6 and aac(6')-Ib-cr genes by CLSI agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
26080,26080,,,5308636,[],CHEMBL1691513,Antimicrobial activity against oqxAB positive Escherichia coli C600 SP8-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26081,26081,,,5308637,[],CHEMBL1691514,Antimicrobial activity against oqxAB positive Escherichia coli C600 D83-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
26082,26082,,,5308638,[],CHEMBL1691515,Antimicrobial activity against oqxAB positive Escherichia coli DH5[alpha] harboring pMD18-T::oqxAB by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
26083,26083,,,5308639,[],CHEMBL1691516,Antimicrobial activity against Escherichia coli DH5[alpha] by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337904,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
26084,26084,,,5308663,[],CHEMBL1694342,Ratio of MIC for Escherichia coli ATCC 25922 expressing qnrA gene to MIC for Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,62.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,62.0
26085,26085,,,5308664,[],CHEMBL1694343,Ratio of MIC for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 to MIC for Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
26086,26086,,,5308665,[],CHEMBL1694344,Ratio of MIC for Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 to MIC for Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
26087,26087,,,5308666,[],CHEMBL1694345,Ratio of MIC for Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 to MIC for Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
26088,26088,,Active,5308667,[],CHEMBL1694654,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene assessed as reduction of viable bacteria at 1 ug/ml after 8 hrs by time kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26089,26089,,Active,5308668,[],CHEMBL1694655,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction of viable bacteria at 1 ug/ml after 6 hrs by time kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26090,26090,,Not Active,5308669,[],CHEMBL1694656,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as reduction of viable bacteria at 4 time MIC after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26091,26091,,Not Active,5308670,[],CHEMBL1694657,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as reduction of viable bacteria at 4 time MIC after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26092,26092,,Not Active,5308671,[],CHEMBL1694658,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as reduction of viable bacteria at 4 time MIC after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26093,26093,,Active,5308672,[],CHEMBL1692361,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as reduction of viable bacteria at 1 ug/ml after 8 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26094,26094,,Active,5308673,[],CHEMBL1692362,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as reduction of viable bacteria at 1 ug/ml after 8 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26095,26095,,Active,5308674,[],CHEMBL1692363,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as reduction of viable bacteria at 1 ug/ml after 8 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26096,26096,,Not Active,5308675,[],CHEMBL1692364,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as reduction of viable bacteria at 1 ug/ml after 8 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26097,26097,,Not Active,5308676,[],CHEMBL1692365,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as reduction of viable bacteria at 1 ug/ml after 8 to 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26098,26098,,Not Active,5308677,[],CHEMBL1692366,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as reduction of viable bacteria at 1 ug/ml after 8 to 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26099,26099,,Not Active,5308678,[],CHEMBL1692367,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as reduction of viable bacteria at 1 ug/ml after 8 to 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26100,26100,,Active,5308679,[],CHEMBL1692368,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as reduction of viable bacteria at 1 ug/ml after 8 to 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338560,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26101,26101,,,5309828,[],CHEMBL1691517,Antimicrobial activity against Pseudomonas aeruginosa PA14 by EUCAST method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687784,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337918,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
26102,26102,,,5309836,[],CHEMBL1691518,Antimicrobial activity against Pseudomonas aeruginosa PA14 mutS gene hypermutant by EUCAST method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687784,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337918,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
26103,26103,,Active,5310942,[],CHEMBL1694943,Inhibition of RNA synthesis in Bacillus subtilis BD54 at 5 X MIC by [5-3H]uridine incorporation assay,F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337518,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
26104,26104,,Active,5310950,[],CHEMBL1694942,Inhibition of DNA synthesis in Bacillus subtilis BD54 at 5 X MIC by [3H]thymidine incorporation assay,F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337518,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
26105,26105,,Not Determined,5310967,[],CHEMBL1694936,Antimicrobial activity against Burkholderia cepacia clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,,,,
26106,26106,,Not Determined,5310972,[],CHEMBL1694935,Antimicrobial activity against Burkholderia thailandensis by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL4513185,Burkholderia thailandensis,Burkholderia thailandensis,57975.0,,,MIC,,,,
26107,26107,,Not Determined,5310977,[],CHEMBL1694934,Antimicrobial activity against Burkholderia pseudomallei DD503 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,,MIC,,,,
26108,26108,,Not Determined,5310982,[],CHEMBL1694933,Antimicrobial activity against Burkholderia mallei ATCC 23344 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,,,,
26109,26109,,Not Determined,5310987,[],CHEMBL1694932,Antimicrobial activity against Yersinia pestis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,,MIC,,,,
26110,26110,,,5310992,[],CHEMBL1694931,Antimicrobial activity against Pseudomonas aeruginosa PAO1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
26111,26111,,,5310997,[],CHEMBL1694930,Antimicrobial activity against Klebsiella pneumoniae 5657 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.2
26112,26112,,,5311002,[],CHEMBL1694883,Antimicrobial activity against Escherichia coli J53 clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,<,1,1,<,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
26113,26113,,,5311007,[],CHEMBL1694882,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.6
26114,26114,,,5311012,[],CHEMBL1694881,Antimicrobial activity against vancomycin-resistant Enterococcus faecium B42762 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,20.0
26115,26115,,,5311017,[],CHEMBL1694880,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 1094 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
26116,26116,,Not Determined,5311022,[],CHEMBL1694879,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
26117,26117,,,5311031,[],CHEMBL1694878,Antimicrobial activity against ciprofloxacin-resistant Bacillus anthracis Ames 105-6 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,ug ml-1,UO_0000274,,100.0
26118,26118,,,5311036,[],CHEMBL1694877,Antimicrobial activity against Mycobacterium smegmatis 700009 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.4
26119,26119,,,5311041,[],CHEMBL1694876,Antimicrobial activity against Mycobacterium smegmatis 35798 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.2
26120,26120,,,5311046,[],CHEMBL1694875,Antimicrobial activity against Mycobacterium smegmatis 19420 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.1
26121,26121,,,5311051,[],CHEMBL1694874,Antimicrobial activity against Enterococcus faecalis 29212 clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.5
26122,26122,,Not Determined,5311056,[],CHEMBL1694873,Antimicrobial activity against Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,,,,
26123,26123,,Not Determined,5311061,[],CHEMBL1694872,Antimicrobial activity against Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
26124,26124,,,5311066,[],CHEMBL1694871,Antimicrobial activity against Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
26125,26125,,Not Determined,5311075,[],CHEMBL1694870,Antimicrobial activity against Bacillus anthracis Ames spores by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,,,,
26126,26126,,,5311080,[],CHEMBL1694869,Antimicrobial activity against Bacillus subtilis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.1
26127,26127,,Not Determined,5311089,[],CHEMBL1694868,Antimicrobial activity against Bacillus anthracis Vollum clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,,,,
26128,26128,,Not Determined,5311094,[],CHEMBL1694867,Antimicrobial activity against Bacillus pumilus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,,MIC,,,,
26129,26129,,,5311099,[],CHEMBL1694866,Antimicrobial activity against Bacillus megaterium clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,0.2
26130,26130,,,5311104,[],CHEMBL1694865,Antimicrobial activity against Bacillus licheniformis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337518,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612626,Bacillus licheniformis,Bacillus licheniformis,1402.0,,,MIC,ug ml-1,UO_0000274,,0.1
26131,26131,,Not Determined,5311109,[],CHEMBL1694864,Antimicrobial activity against Bacillus brevis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL614624,Brevibacillus brevis,Brevibacillus brevis,1393.0,,,MIC,,,,
26132,26132,,Not Determined,5311118,[],CHEMBL1694863,Antimicrobial activity against Bacillus anthracis Ames by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337518,,1,0,,,MIC,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,,,,
26133,26133,,Active,5311123,[],CHEMBL1694862,Inhibition of spore outgrowth in Bacillus anthracis Sterne spores assessed as reduction in bacterial CFU count at 0.1 ug/ml after 4 hrs relative to untreated control,F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337518,,1,0,,,Inhibition,%,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,INH,,UO_0000187,,
26134,26134,,,5311171,[],CHEMBL1694182,Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,26.0
26135,26135,,,5311172,[],CHEMBL1693544,Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
26136,26136,,,5311173,[],CHEMBL1694181,Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type U assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26137,26137,,,5311174,[],CHEMBL1693543,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26138,26138,,,5311175,[],CHEMBL1694183,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,89.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,89.0
26139,26139,,,5311176,[],CHEMBL1693542,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,28.0
26140,26140,,,5311177,[],CHEMBL1694184,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,78.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,78.0
26141,26141,,,5311178,[],CHEMBL1694185,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type U3 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26142,26142,,,5311179,[],CHEMBL1694300,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type U5 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26143,26143,,,5311180,[],CHEMBL1694301,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26144,26144,,,5311181,[],CHEMBL1694302,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,4.0
26145,26145,,,5311182,[],CHEMBL1694303,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26146,26146,,,5311183,[],CHEMBL1694304,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 6 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26147,26147,,,5311184,[],CHEMBL1694305,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U1 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
26148,26148,,,5311185,[],CHEMBL1694306,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U6 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26149,26149,,,5311186,[],CHEMBL1694307,Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U8 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26150,26150,,,5311187,[],CHEMBL1694308,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26151,26151,,,5311188,[],CHEMBL1694309,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26152,26152,,,5311189,[],CHEMBL1694310,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26153,26153,,,5311190,[],CHEMBL1694311,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
26154,26154,,,5311191,[],CHEMBL1694312,Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type U3 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
26155,26155,,,5311192,[],CHEMBL1694313,Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 6 assessed as percent susceptible isolates by kirby-bauer method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687786,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337928,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
26156,26156,,Not Active,5311310,[],CHEMBL1694314,Antimicrobial activity against Acinetobacter baumannii clinical isolate harboring plasmid encoded ISAba1-blaOXA-51-like gene with nuc upstream sequence by agar dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687787,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337940,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
26157,26157,,,5311358,[],CHEMBL1694459,Antimicrobial activity against multidrug-resistant Neisseria gonorrhoeae isolates assessed as resistant isolates by disk susceptibility test,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687789,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337948,=,1,0,=,,Activity,%,,88.6,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,%,UO_0000187,,88.6
26158,26158,,,5311359,[],CHEMBL1694460,Antimicrobial activity against multidrug-resistant Neisseria gonorrhoeae isolates harboring mosaic penicillin-binding protein 2 penA assessed as resistant isolates by disk susceptibility test,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687789,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337948,=,1,0,=,,Activity,%,,100.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,%,UO_0000187,,100.0
26159,26159,,,5311360,[],CHEMBL1694461,Antimicrobial activity against Neisseria gonorrhoeae isolates harboring non-mosaic penicillin-binding protein 2 penA assessed as resistant isolates by disk susceptibility test,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687789,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337948,=,1,0,=,,Activity,%,,84.3,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,%,UO_0000187,,84.3
26160,26160,,,5311401,[],CHEMBL1694463,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from human assessed as percentage of resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337959,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
26161,26161,,,5311402,[],CHEMBL1694464,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from animals and food assessed as percentage of resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337959,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
26162,26162,,,5311403,[],CHEMBL1695785,Antimicrobial activity against eaeA positive verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337959,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
26163,26163,,,5311404,[],CHEMBL1695786,Antimicrobial activity against eaeA negative verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337959,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
26164,26164,,Active,5312295,[],CHEMBL1694944,"Inhibition of protein synthesis in Bacillus subtilis BD54 at 5 X MIC by L-[4,5-3H]leucine incorporation assay",F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337518,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
26165,26165,,Active,5312299,[],CHEMBL1694945,Inhibition of cell wall synthesis in Bacillus subtilis BD54 at 5 X MIC by N-acetyl-D-[1-3H] glucosamine incorporation assay,F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687745,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337518,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
26166,26166,,,5313914,[],CHEMBL1690025,Antibacterial activity against Citrobacter spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614437,Citrobacter,Citrobacter,544.0,,,MIC50,ug ml-1,UO_0000274,,8.0
26167,26167,,,5313924,[],CHEMBL1690026,Antibacterial activity against Escherichia coli by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,16.0
26168,26168,,,5313925,[],CHEMBL1690026,Antibacterial activity against Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,16.0
26169,26169,,,5313938,[],CHEMBL1690027,Antibacterial activity against Enterobacter spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,MIC50,ug ml-1,UO_0000274,,1.0
26170,26170,,,5313939,[],CHEMBL1690027,Antibacterial activity against Enterobacter spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,MIC90,ug ml-1,UO_0000274,,16.0
26171,26171,,,5313952,[],CHEMBL1690028,Antibacterial activity against Klebsiella spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,MIC50,ug ml-1,UO_0000274,,16.0
26172,26172,,,5313953,[],CHEMBL1690028,Antibacterial activity against Klebsiella spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,MIC90,ug ml-1,UO_0000274,,16.0
26173,26173,,,5313966,[],CHEMBL1690029,Antibacterial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,2.0
26174,26174,,,5313967,[],CHEMBL1690029,Antibacterial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,16.0
26175,26175,,,5313977,[],CHEMBL1690030,Antibacterial activity against indole positive Proteae by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,16.0
26176,26176,,,5313984,[],CHEMBL1690031,Antibacterial activity against Serratia spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL613282,Serratia sp.,Serratia sp.,616.0,,,MIC50,ug ml-1,UO_0000274,,4.0
26177,26177,,,5313994,[],CHEMBL1690032,Antibacterial activity against Staphylococcus spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50,ug ml-1,UO_0000274,,16.0
26178,26178,,,5313995,[],CHEMBL1690032,Antibacterial activity against Staphylococcus spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC90,ug ml-1,UO_0000274,,16.0
26179,26179,,,5314008,[],CHEMBL1690033,Antibacterial activity against Acinetobacter spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC50,ug ml-1,UO_0000274,,16.0
26180,26180,,,5314009,[],CHEMBL1690033,Antibacterial activity against Acinetobacter spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC90,ug ml-1,UO_0000274,,16.0
26181,26181,,,5314022,[],CHEMBL1690034,Antibacterial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,8.0
26182,26182,,,5314023,[],CHEMBL1690034,Antibacterial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687796,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338130,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,16.0
26183,26183,,,5315481,[],CHEMBL1690240,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 56 (494) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
26184,26184,,,5315482,[],CHEMBL1690239,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 152 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
26185,26185,,,5315483,[],CHEMBL1690241,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 156 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26186,26186,,,5315484,[],CHEMBL1690242,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 145 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
26187,26187,,,5315485,[],CHEMBL1690243,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 336 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26188,26188,,,5315486,[],CHEMBL1690244,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 360 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26189,26189,,,5315487,[],CHEMBL1690245,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 412 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26190,26190,,,5315488,[],CHEMBL1690246,Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 38 (Mu3) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26191,26191,,,5315489,[],CHEMBL1690247,Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 443 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26192,26192,,,5315490,[],CHEMBL1690248,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 435 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26193,26193,,,5315491,[],CHEMBL1690249,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 440 (A6298) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26194,26194,,,5315492,[],CHEMBL1690250,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 453 (NRS23) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26195,26195,,,5315493,[],CHEMBL1690251,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 454 (NRS404) by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338169,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26196,26196,,drug-induced liver injury reported,5317224,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341010,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
26197,26197,,drug-induced liver injury reported,5318175,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341010,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
26198,26198,,no drug-induced liver injury reported,5319126,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341010,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
26199,26199,,Inactive,5320106,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,,1,0,,,Composite Activity - Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Score,,,,
26200,26200,,,5320107,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,=,1,0,=,,Composite Activity - Active,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Active,,,,0.0
26201,26201,,,5320108,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,=,1,0,=,,Composite Activity - Marginal,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Marginal,,,,1.0
26202,26202,,Inactive,5320109,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,,1,0,,,Alkaline Phosphatase Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Activity Score,,,,
26203,26203,,,5320110,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,=,1,0,=,,Alkaline Phosphatase Increase - Index Value,,,2.3,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Index Value,,,,2.3
26204,26204,,,5320111,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,>=,1,0,>=,,Alkaline Phosphatase Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Number of Reports,,,,4.0
26205,26205,,Marginally Active,5320112,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,,1,0,,,SGOT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Activity Score,,,,
26206,26206,,,5320113,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,=,1,0,=,,SGOT Increase - Index Value,,,3.1,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Index Value,,,,3.1
26207,26207,,,5320114,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,>=,1,0,>=,,SGOT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Number of Reports,,,,4.0
26208,26208,,Inactive,5320115,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,,1,0,,,SGPT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Activity Score,,,,
26209,26209,,,5320116,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,=,1,0,=,,SGPT Increase - Index Value,,,2.1,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Index Value,,,,2.1
26210,26210,,,5320117,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,>=,1,0,>=,,SGPT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Number of Reports,,,,4.0
26211,26211,,Inactive,5320118,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,,1,0,,,LDH Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Activity Score,,,,
26212,26212,,,5320119,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,=,1,0,=,,LDH Increase - Index Value,,,0.9,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Index Value,,,,0.9
26213,26213,,,5320120,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,>=,1,0,>=,,LDH Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Number of Reports,,,,4.0
26214,26214,,Inactive,5320121,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,,1,0,,,GGT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Activity Score,,,,
26215,26215,,,5320122,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,=,1,0,=,,GGT Increase - Index Value,,,0.8,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Index Value,,,,0.8
26216,26216,,,5320123,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1341961,>=,1,0,>=,,GGT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Number of Reports,,,,4.0
26217,26217,,,5986581,[],CHEMBL1112930,Absolute bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158536,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,910320,=,1,1,=,,F,%,,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,70.0
26218,26218,,inconclusive,5996115,[],CHEMBL1741325,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1201862,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,978481,,7,0,,,AC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,AC50,,,,
26219,26219,,inconclusive,6008000,[],CHEMBL1741322,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1201862,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.8,0,http://www.openphacts.org/units/Nanomolar,978481,=,7,1,=,,AC50,nM,,15848.93,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,AC50,uM,UO_0000065,,15.84893192
26220,26220,,inactive,6033467,[],CHEMBL1741321,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1201862,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,978481,,7,0,,,AC50,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,AC50,,,,
26221,26221,,inactive,6049841,[],CHEMBL1741324,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1201862,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,978481,,7,0,,,AC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,AC50,,,,
26222,26222,,inactive,6052968,[],CHEMBL1741323,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1201862,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,978481,,7,0,,,AC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,AC50,,,,
26223,26223,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",transporter substrate,6073590,[],CHEMBL1743147,"Substrates of transporters of clinical importance in the absorption and disposition of drugs, OAT1",A,,,BAO_0000375,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1743141,Nat Rev Drug Discov,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1393604,,1,0,,,Activity,,,,CHEMBL1641347,Homo sapiens,Solute carrier family 22 member 6,9606.0,,,Activity,,,,
26224,26224,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Inhibitor,6074572,[],CHEMBL1743274,"Clinically relevant inhibitors of human liver microsomal P450 enzymes, isoform CYP1A2",A,,,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1743201,,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1394169,,1,0,,,Activity,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Activity,,,,
26225,26225,,,6148647,[],CHEMBL1763732,Antibacterial activity against Staphylococcus aureus MTCC 96 for 24 hrs by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759833,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1412946,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
26226,26226,,,6148657,[],CHEMBL1763731,Antibacterial activity against Pseudomonas aeruginosa MTCC 741 for 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759833,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1412946,=,1,1,=,,IZ,mm,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,25.0
26227,26227,,,6148658,[],CHEMBL1763730,Antibacterial activity against Escherichia coli MTCC 1652 for 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759833,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1412946,=,1,1,=,,IZ,mm,,25.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,25.3
26228,26228,,,6148665,[],CHEMBL1763729,Antibacterial activity against Bacillus subtilis MTCC 121 for 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759833,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1412946,=,1,1,=,,IZ,mm,,26.3,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,26.3
26229,26229,,,6148681,[],CHEMBL1763728,Antibacterial activity against Staphylococcus aureus MTCC 96 for 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759833,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1412946,=,1,1,=,,IZ,mm,,27.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,27.6
26230,26230,,,6148695,[],CHEMBL1763733,Antibacterial activity against Bacillus subtilis MTCC 121 for 24 hrs by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759833,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1412946,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,5.0
26231,26231,,,6150494,[],CHEMBL1763272,Antibacterial activity against Klebsiella pneumoniae clinical isolate after 24 hrs by broth dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,0,=,,MBC,ug ml-1,,12.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,ug ml-1,UO_0000274,,12.5
26232,26232,,,6150503,[],CHEMBL1763272,Antibacterial activity against Klebsiella pneumoniae clinical isolate after 24 hrs by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,12.5
26233,26233,,,6150512,[],CHEMBL1763271,Antibacterial activity against Streptococcus pyogenes clinical isolate after 24 hrs by broth dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,0,=,,MBC,ug ml-1,,12.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,12.5
26234,26234,,,6150522,[],CHEMBL1763271,Antibacterial activity against Streptococcus pyogenes clinical isolate after 24 hrs by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,12.5
26235,26235,,,6150532,[],CHEMBL1763266,Antibacterial activity against Pseudomonas aeruginosa ATCC 27583 after 24 hrs by broth dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,0,=,,MBC,ug ml-1,,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,12.5
26236,26236,,,6150544,[],CHEMBL1763266,Antibacterial activity against Pseudomonas aeruginosa ATCC 27583 after 24 hrs by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,1,=,,MIC,ug.mL-1,,6.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,6.5
26237,26237,,,6151739,[],CHEMBL1763267,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,0,=,,MBC,ug ml-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,12.5
26238,26238,,,6151749,[],CHEMBL1763267,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
26239,26239,,,6151760,[],CHEMBL1763268,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,0,=,,MBC,ug ml-1,,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,12.5
26240,26240,,,6151772,[],CHEMBL1763268,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413410,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
26241,26241,,,6151784,[],CHEMBL1763270,Antibacterial activity against Klebsiella pneumoniae clinical isolate after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1413410,=,1,1,=,,IZ,mm,,19.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,DIZ,mm,UO_0000016,,19.0
26242,26242,,,6151795,[],CHEMBL1763274,Antibacterial activity against Pseudomonas aeruginosa ATCC 27583 after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1413410,=,1,1,=,,IZ,mm,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,32.0
26243,26243,,,6151808,[],CHEMBL1763269,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1413410,=,1,1,=,,IZ,mm,,270.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,270.0
26244,26244,,,6151821,[],CHEMBL1763273,Antibacterial activity against Streptococcus pyogenes clinical isolate after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1413410,=,1,1,=,,IZ,mm,,23.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,DIZ,mm,UO_0000016,,23.0
26245,26245,,,6151833,[],CHEMBL1763275,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759880,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1413410,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,22.0
26246,26246,,,6151909,[],CHEMBL1763337,Antibacterial activity against methicillin- resistant Staphylococcus aureus ATCC 25923 after 24 hrs by spectrophotometry,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759957,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413807,=,1,1,=,,MIC,ug.mL-1,,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.09
26247,26247,,,6151923,[],CHEMBL1763336,Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by spectrophotometry,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759957,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413807,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.19
26248,26248,,,6151929,[],CHEMBL1763338,Antibacterial activity against methicillin- resistant and vancomycin resistant Staphylococcus aureus ATCC 29213 after 24 hrs by spectrophotometry,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759957,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413807,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.38
26249,26249,,,6154298,[],CHEMBL1763526,Antibacterial activity against Staphylococcus aureus ATCC 25825 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1414195,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
26250,26250,,,6154316,[],CHEMBL1763527,Antibacterial activity against Escherichia coli ATCC 25835 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1414195,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
26251,26251,,,6154334,[],CHEMBL1763528,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1414195,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.5
26252,26252,,,6154352,[],CHEMBL1763529,Antibacterial activity against Salmonella typhi ATCC 24915 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1414195,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,12.5
26253,26253,,,6154370,[],CHEMBL1763530,Antibacterial activity against Bacillus subtilis ATCC 451 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1414195,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,50.0
26254,26254,,,6154388,[],CHEMBL1763531,Antibacterial activity against Klebsiella pneumoniae ATCC 15490 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1414195,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,50.0
26255,26255,,,6155600,[],CHEMBL1763526,Antibacterial activity against Staphylococcus aureus ATCC 25825 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1414195,=,1,0,=,,-logMIC,,,4.602,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,4.602
26256,26256,,,6155618,[],CHEMBL1763527,Antibacterial activity against Escherichia coli ATCC 25835 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1414195,=,1,0,=,,-logMIC,,,4.301,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,4.301
26257,26257,,,6155636,[],CHEMBL1763528,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1414195,=,1,0,=,,-logMIC,,,4.903,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,-logMIC,,,,4.903
26258,26258,,,6155654,[],CHEMBL1763529,Antibacterial activity against Salmonella typhi ATCC 24915 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1414195,=,1,0,=,,-logMIC,,,4.903,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,-logMIC,,,,4.903
26259,26259,,,6155672,[],CHEMBL1763530,Antibacterial activity against Bacillus subtilis ATCC 451 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1414195,=,1,0,=,,-logMIC,,,4.301,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,4.301
26260,26260,,,6155690,[],CHEMBL1763531,Antibacterial activity against Klebsiella pneumoniae ATCC 15490 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1759834,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1414195,=,1,0,=,,-logMIC,,,4.301,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,-logMIC,,,,4.301
26261,26261,,,6172600,[],CHEMBL1767999,Antimicrobial activity against Bacillus cereus ATCC 11778 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.3
26262,26262,,,6172609,[],CHEMBL1768000,Antimicrobial activity against Bacillus megaterium ATCC 19213 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.007,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,0.007
26263,26263,,,6172618,[],CHEMBL1768001,Antimicrobial activity against Bacillus subtilis ATCC 6633 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.03
26264,26264,,,6172627,[],CHEMBL1768002,Antimicrobial activity against Bacillus thuringiensis var.kurstaki BGSC 4D1 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
26265,26265,,,6172636,[],CHEMBL1768003,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
26266,26266,,,6172645,[],CHEMBL1768004,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 72 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
26267,26267,,,6172654,[],CHEMBL1768005,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 4790 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
26268,26268,,,6172663,[],CHEMBL1768006,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.07
26269,26269,,,6172672,[],CHEMBL1768007,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus epidermidis clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,100.0
26270,26270,,,6172681,[],CHEMBL1768008,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.7
26271,26271,,,6172690,[],CHEMBL1768009,Antimicrobial activity against quinilone-pencillin-resistant Acinetobacter baumannii clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,100.0
26272,26272,,,6172699,[],CHEMBL1768010,Antimicrobial activity against Escherichia coli ATCC 8739 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
26273,26273,,,6172708,[],CHEMBL1768011,Antimicrobial activity against quinilone-pencillin-resistant Escherichia coli clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,100.0
26274,26274,,,6172717,[],CHEMBL1768012,Antimicrobial activity against Haemophilus influenzae ATCC 19418 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.15
26275,26275,,,6172726,[],CHEMBL1768013,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.07
26276,26276,,,6172735,[],CHEMBL1768014,Antimicrobial activity against Saccharomyces cerevisiae ATCC 9763 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,100.0
26277,26277,,,6172745,[],CHEMBL1768015,Antimicrobial activity against Candida tropicalis ATCC 1369 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,,MIC,ug ml-1,UO_0000274,,100.0
26278,26278,,,6172755,[],CHEMBL1768201,Antimicrobial activity against Aspergillus niger ATCC 6275 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,MIC,ug ml-1,UO_0000274,,100.0
26279,26279,,,6173388,[],CHEMBL1768202,Inhibition of Escherichia coli DNA gyrase assessed as reduction of DNA supercoiling activity using pBR322 DNA substrate after 30 mins by electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,IC50,ug.mL-1,,0.34,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.34
26280,26280,,,6173392,[],CHEMBL1768203,Inhibition of Escherichia coli topoisomerase 4 assessed as decatenation of kDNA after 30 mins by electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418179,=,1,1,=,,IC50,ug.mL-1,,4.6,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,4.6
26281,26281,,,6173672,[],CHEMBL1769835,Apparent permeability across human Caco2 cell membrane after 2 hrs by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1764994,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1415539,=,1,0,=,,logPapp,,,-5.77,CHEMBL614058,Homo sapiens,Caco-2,9606.0,,,logPapp,,,,-5.77
26282,26282,,,6177169,[],CHEMBL1772111,Bactericidal activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,0,=,,MBC,ug ml-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,50.0
26283,26283,,,6177176,[],CHEMBL1772110,Bactericidal activity against clinical isolate of Klebsiella pneumoniae after 18 to 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,0,=,,MBC,ug ml-1,,50.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,ug ml-1,UO_0000274,,50.0
26284,26284,,,6177183,[],CHEMBL1772109,Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,0,=,,MBC,ug ml-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,25.0
26285,26285,,,6177190,[],CHEMBL1772108,Bactericidal activity against methicillin-resistant Staphylococcus aureus after 18 to 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,0,=,,MBC,ug ml-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,50.0
26286,26286,,,6177197,[],CHEMBL1772107,Bactericidal activity against clinical isolate of Streptococcus pyogenes after 18 to 24 hrs by colony counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,0,=,,MBC,ug ml-1,,50.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,50.0
26287,26287,,,6177204,[],CHEMBL1772106,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,12.5
26288,26288,,,6177211,[],CHEMBL1772105,Antibacterial activity against clinical isolate of Klebsiella pneumoniae after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,12.5
26289,26289,,,6177218,[],CHEMBL1772104,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.5
26290,26290,,,6177225,[],CHEMBL1772103,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
26291,26291,,,6177232,[],CHEMBL1772102,Antibacterial activity against clinical isolate of Streptococcus pyogenes after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1419874,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,12.5
26292,26292,,,6177239,[],CHEMBL1772101,Antibacterial activity against Escherichia coli ATCC 25922 at 30 ug after 24 hrs by Halo zone test,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1419874,=,1,1,=,,IZ,mm,,26.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,26.0
26293,26293,,,6177240,[],CHEMBL1772100,Antibacterial activity against clinical isolate of Klebsiella pneumoniae at 30 ug after 24 hrs by Halo zone test,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1419874,=,1,1,=,,IZ,mm,,18.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,DIZ,mm,UO_0000016,,18.0
26294,26294,,,6177241,[],CHEMBL1772099,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 30 ug after 24 hrs by Halo zone test,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1419874,=,1,1,=,,IZ,mm,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,32.0
26295,26295,,,6177242,[],CHEMBL1772098,Antibacterial activity against methicillin-resistant Staphylococcus aureus at 30 ug after 24 hrs by Halo zone test,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1419874,=,1,1,=,,IZ,mm,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,25.0
26296,26296,,,6177243,[],CHEMBL1772097,Antibacterial activity against clinical isolate of Streptococcus pyogenes after 24 hrs at 30 ug by Halo zone test,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770075,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1419874,=,1,1,=,,IZ,mm,,24.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,DIZ,mm,UO_0000016,,24.0
26297,26297,,,6183224,[],CHEMBL1772139,Antimicrobial activity against Bacillus megaterium ATCC 9885 after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1420202,=,1,1,=,,IZ,mm,,16.0,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,DIZ,mm,UO_0000016,,16.0
26298,26298,,,6183242,[],CHEMBL1772088,Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1420202,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,21.0
26299,26299,,,6183260,[],CHEMBL1772140,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1420202,=,1,1,=,,IZ,mm,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,16.0
26300,26300,,,6183278,[],CHEMBL1772141,Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1420202,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,DIZ,mm,UO_0000016,,21.0
26301,26301,,,6183296,[],CHEMBL1772142,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27953 after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1420202,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,21.0
26302,26302,,,6183314,[],CHEMBL1772143,Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1420202,=,1,1,=,,IZ,mm,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,16.0
26303,26303,,,6183332,[],CHEMBL1772172,Antimicrobial activity against Candida albicans NRRL Y-477 after 48 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1420202,<=,1,1,<=,,IZ,mm,,4.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,DIZ,mm,UO_0000016,,4.0
26304,26304,,,6183350,[],CHEMBL1772173,Antimicrobial activity against Aspergillus niger after 48 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1420202,<=,1,1,<=,,IZ,mm,,4.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,DIZ,mm,UO_0000016,,4.0
26305,26305,,,6183353,[],CHEMBL1772174,Antimicrobial activity against Bacillus megaterium ATCC 9885 after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1420202,=,1,1,=,,MIC,ug.mL-1,,21.9,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,21.9
26306,26306,,,6183358,[],CHEMBL1772175,Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1420202,=,1,1,=,,MIC,ug.mL-1,,10.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,10.9
26307,26307,,,6183362,[],CHEMBL1772176,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1420202,=,1,1,=,,MIC,ug.mL-1,,21.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,21.9
26308,26308,,,6183364,[],CHEMBL1772177,Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1420202,=,1,1,=,,MIC,ug.mL-1,,10.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,10.9
26309,26309,,,6183366,[],CHEMBL1772178,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27953 after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1420202,=,1,1,=,,MIC,ug.mL-1,,10.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.9
26310,26310,,,6183368,[],CHEMBL1772179,Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770090,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1420202,=,1,1,=,,MIC,ug.mL-1,,21.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,21.9
26311,26311,,,6183855,[],CHEMBL1771897,Antituberculosis activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770066,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1419472,=,1,1,=,,MIC,nM,,4700.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.7
26312,26312,,,6183953,[],CHEMBL1771905,Antituberculosis activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1770089,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1419681,=,1,1,=,,MIC,nM,,9440.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,9.44
26313,26313,,,6184720,[],CHEMBL1775353,Antibacterial activity against Escherichia coli ATCC25922 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421985,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
26314,26314,,,6184797,[],CHEMBL1775350,Inhibition of wild-type Staphylococcus aureus topoisomerase 4-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.52,0,http://www.openphacts.org/units/Nanomolar,1421985,=,1,1,=,,IC50,nM,,3000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,3.0
26315,26315,,,6184804,[],CHEMBL1775351,Inhibition of wild-type Staphylococcus aureus DNA gyrase assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772978,J Med Chem,2011.0,"{'bei': '12.70', 'le': '0.24', 'lle': '2.63', 'sei': '5.64'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.21,1,http://www.openphacts.org/units/Nanomolar,1421985,=,1,1,=,,IC50,nM,,62000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,62.0
26316,26316,,,6184811,[],CHEMBL1775357,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421985,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
26317,26317,,,6184818,[],CHEMBL1775519,Inhibition of Staphylococcus aureus topoisomerase 4 Ser80Phe mutant-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.24,0,http://www.openphacts.org/units/Nanomolar,1421985,=,1,1,=,,IC50,nM,,57000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,57.0
26318,26318,,,6184825,[],CHEMBL1775520,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,P20831,S84L,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1772978,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1421985,>,1,1,>,,IC50,nM,,200000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,IC50,uM,UO_0000065,,200.0
26319,26319,,,6194266,[],CHEMBL1776167,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth inhibition at 5 ug/ml by microplate assay,F,,,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772983,J Nat Prod,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1422367,=,1,0,=,,GI,%,,73.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,GI,%,UO_0000187,,73.0
26320,26320,,,6194267,[],CHEMBL1776166,Inhibition of Pseudomonas aeruginosa ATCC 27853 biofilm formation at 5 ug/ml after 24 hrs using crystal violet staining by spectrophotometry analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772983,J Nat Prod,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1422367,=,1,1,=,,Inhibition,%,,51.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,INH,%,UO_0000187,,51.0
26321,26321,,,6199608,[],CHEMBL1775349,Cytotoxicity against human Hep2 cells after 72 hrs by alamar blue assay,A,,,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1421985,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,100.0
26322,26322,,,6199660,[],CHEMBL1775348,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421985,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
26323,26323,,,6199676,[],CHEMBL1775352,Antibacterial activity against methicillin- and quinolone-resistant Staphylococcus aureus ATCC700699 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421985,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
26324,26324,,,6209019,[],CHEMBL1781603,Antibacterial activity against Staphylococcus aureus ATCC 13709,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
26325,26325,,,6209020,[],CHEMBL1781602,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-49,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
26326,26326,,,6209021,[],CHEMBL1781604,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-52,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
26327,26327,,,6209022,[],CHEMBL1781605,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
26328,26328,,,6209023,[],CHEMBL1781606,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 08-17,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
26329,26329,,,6209024,[],CHEMBL1781746,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 08-18,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
26330,26330,,,6209025,[],CHEMBL1781747,Antibacterial activity against Streptococcus pneumoniae ATCC 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
26331,26331,,,6209026,[],CHEMBL1781748,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 08-2,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
26332,26332,,,6209027,[],CHEMBL1781749,Antibacterial activity against Enterococcus faecalis ATCC 51299,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
26333,26333,,,6209028,[],CHEMBL1781750,Antibacterial activity against vancomycin-resistant Enterococcus faecalis EFL1004,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
26334,26334,,,6209029,[],CHEMBL1781751,Antibacterial activity against Streptococcus pyogenes 556,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,1.0
26335,26335,,,6209030,[],CHEMBL1781752,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
26336,26336,,,6209031,[],CHEMBL1781753,Antibacterial activity against Extended spectrum beta-lactamase producing Escherichia coli 08-5,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
26337,26337,,,6209032,[],CHEMBL1781754,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
26338,26338,,,6209033,[],CHEMBL1781755,Antibacterial activity against Pseudomonas aeruginosa 17,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
26339,26339,,,6209034,[],CHEMBL1781756,Antibacterial activity against Shigella sonnei 51592,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.03
26340,26340,,,6209035,[],CHEMBL1781757,Antibacterial activity against Bacillus typhi 50035,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,0.03
26341,26341,,,6209036,[],CHEMBL1781758,Antibacterial activity against Enterobacter cloacae 45301,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
26342,26342,,,6209037,[],CHEMBL1781759,Antibacterial activity against Acinetobacter calcoaceticus 25001,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,1.0
26343,26343,,,6209038,[],CHEMBL1781760,Antibacterial activity against Enterobacter aerogenes 45102,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.03
26344,26344,,,6209039,[],CHEMBL1781761,Antibacterial activity against Serratia marcescens 41002,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.25
26345,26345,,,6209040,[],CHEMBL1781762,Antibacterial activity against Morganella morganii 49086,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.03
26346,26346,,,6209041,[],CHEMBL1781763,Antibacterial activity against Proteus rettgeri 49006,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.03
26347,26347,,,6209042,[],CHEMBL1781764,Antibacterial activity against Proteus vulgaris 56,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424191,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.03
26348,26348,,,6209212,[],CHEMBL1781017,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.064
26349,26349,,,6209218,[],CHEMBL1780940,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
26350,26350,,,6209220,[],CHEMBL1780946,Antibacterial activity against methicillin-resistant Staphylococcus aureus CIP 65.25 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
26351,26351,,,6209224,[],CHEMBL1780941,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
26352,26352,,,6209235,[],CHEMBL1780942,Antibacterial activity against Staphylococcus aureus ATCC 9144 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
26353,26353,,,6209246,[],CHEMBL1780943,Antibacterial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
26354,26354,,,6209257,[],CHEMBL1780944,Antibacterial activity against Staphylococcus aureus CIP 65.6 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
26355,26355,,,6209268,[],CHEMBL1780945,Antibacterial activity against Staphylococcus aureus CIP 103428 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
26356,26356,,,6209286,[],CHEMBL1780947,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
26357,26357,,,6209295,[],CHEMBL1780948,Antibacterial activity against vancomycin intermediate Staphylococcus aureus ATCC 106414 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
26358,26358,,,6209304,[],CHEMBL1780949,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,0.25
26359,26359,,,6209315,[],CHEMBL1780950,Antibacterial activity against Staphylococcus epidermidis CIP 81.55 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,0.25
26360,26360,,,6209326,[],CHEMBL1780951,Antibacterial activity against Staphylococcus epidermidis CIP 103627 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,0.25
26361,26361,,,6209337,[],CHEMBL1780952,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.5
26362,26362,,,6209346,[],CHEMBL1780953,Antibacterial activity against Streptococcus pneumoniae ATCC 6303 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.5
26363,26363,,,6209672,[],CHEMBL1781018,Antibacterial activity against Haemophilus influenzae ATCC 49766 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,mg/L,UO_0000274,,0.5
26364,26364,,,6209673,[],CHEMBL1780957,Antibacterial activity against Enterococcus faecium CIP 54.32 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,mg/L,UO_0000274,,1.0
26365,26365,,,6209674,[],CHEMBL1780958,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg/L,UO_0000274,,1.0
26366,26366,,,6209834,[],CHEMBL1780959,Antibacterial activity against Klebsiella pneumoniae ATCC 35657 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.016
26367,26367,,,6209835,[],CHEMBL1781013,Antibacterial activity against Enterobacter cloacae ATCC 13047 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,mg/L,UO_0000274,,0.016
26368,26368,,,6209836,[],CHEMBL1781014,Antibacterial activity against Serratia marcescens CIP 103551 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,mg/L,UO_0000274,,0.016
26369,26369,,,6209837,[],CHEMBL1781015,Antibacterial activity against Pseudomonas aeruginosa CIP 5933 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,0.016
26370,26370,,,6209838,[],CHEMBL1781016,Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,0.016
26371,26371,,,6209839,[],CHEMBL1780954,Antibacterial activity against Streptococcus agalactiae ATCC 12400 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,mg/L,UO_0000274,,0.25
26372,26372,,,6209840,[],CHEMBL1780955,Antibacterial activity against Streptococcus pyogenes CIP 104226 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg/L,UO_0000274,,0.25
26373,26373,,,6209841,[],CHEMBL1780956,Antibacterial activity against Streptococcus mitis CIP 103335 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777764,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,mg/L,UO_0000274,,0.25
26374,26374,,,6211005,[],CHEMBL1781651,Antibacterial activity against Escherichia coli NCIM 2065 at 100 ug/ml after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777684,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1425588,=,1,1,=,,IZ,mm,,26.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,26.0
26375,26375,,,6211022,[],CHEMBL1781650,Antibacterial activity against Bacillus subtilis NCIM 2063 at 100 ug/ml after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777684,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1425588,=,1,1,=,,IZ,mm,,18.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,18.0
26376,26376,,,6211042,[],CHEMBL1781649,Antibacterial activity against Staphylococcus aureus NCIM 2079 at 100 ug/ml after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777684,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1425588,=,1,1,=,,IZ,mm,,29.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,29.0
26377,26377,,,6211123,[],CHEMBL1781652,Antibacterial activity against Pseudomonas aeruginosa NCIM 5029 at 100 ug/ml after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777684,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1425588,=,1,1,=,,IZ,mm,,18.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,18.0
26378,26378,,,6211702,[],CHEMBL1780757,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1777730,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1424680,=,1,1,=,,MIC,nM,,4710.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.71
26379,26379,,,6213194,[],CHEMBL1786526,Antibacterial activity against Klebsiella pneumoniae after 18 to 24 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781906,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427813,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
26380,26380,,,6213223,[],CHEMBL1786527,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781906,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427813,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
26381,26381,,,6217297,[],CHEMBL1785187,Antimycobacterial activity against Mycobacterium smegmatis ATCC 14468 after 3 days by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781899,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427185,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.125
26382,26382,,Not Determined,6217330,[],CHEMBL1785188,Antimycobacterial activity against Mycobacterium smegmatis mc2155 after 3 days by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781899,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1427185,,1,0,,,MIC,,,,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,,,,
26383,26383,,Not Determined,6217363,[],CHEMBL1786604,Antimycobacterial activity against Mycobacterium fortuitum ATCC 6841 after 3 days by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781899,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1427185,,1,0,,,MIC,,,,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,,,,
26384,26384,,Not Determined,6217396,[],CHEMBL1786605,Antimycobacterial activity against Mycobacterium phlei ATCC 11758 after 3 days by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781899,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1427185,,1,0,,,MIC,,,,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,,MIC,,,,
26385,26385,,Not Determined,6217429,[],CHEMBL1786606,Cytotoxicity against human MRC5 cells assessed as cell viability at 100 uM after 72 hrs by XTT assay,A,,,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781899,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1427185,,1,0,,,Activity,,,,CHEMBL614181,Homo sapiens,MRC5,9606.0,,,Activity,,,,
26386,26386,,Not Determined,6217462,[],CHEMBL1786607,Cytotoxicity against human MRC5 cells assessed as cell viability at 30 uM after 72 hrs by XTT assay,A,,,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781899,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1427185,,1,0,,,Activity,,,,CHEMBL614181,Homo sapiens,MRC5,9606.0,,,Activity,,,,
26387,26387,,,6220680,[],CHEMBL1787231,Antibacterial activity against Mycobacterium intracellular ATCC 23068 by alamar blue method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,>,1,0,>,,MBC,ug ml-1,,20.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MBC,ug ml-1,UO_0000274,,20.0
26388,26388,,,6220681,[],CHEMBL1787227,Antibacterial activity against Staphylococcus aureus ATCC 29213 by NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,1,=,,IC50,ug.mL-1,,0.07,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.07
26389,26389,,,6220682,[],CHEMBL1787227,Antibacterial activity against Staphylococcus aureus ATCC 29213 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
26390,26390,,,6220683,[],CHEMBL1787227,Antibacterial activity against Staphylococcus aureus ATCC 29213 by NCCLS method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.5
26391,26391,,,6220684,[],CHEMBL1787228,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,1,=,,IC50,ug.mL-1,,0.07,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.07
26392,26392,,,6220685,[],CHEMBL1787228,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
26393,26393,,,6220686,[],CHEMBL1787228,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by NCCLS method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.5
26394,26394,,,6220687,[],CHEMBL1787229,Antibacterial activity against Escherichia coli by NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,1,=,,IC50,ug.mL-1,,0.005,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,ug ml-1,UO_0000274,,0.005
26395,26395,,,6220688,[],CHEMBL1787229,Antibacterial activity against Escherichia coli by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3
26396,26396,,,6220689,[],CHEMBL1787229,Antibacterial activity against Escherichia coli by NCCLS method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,0,=,,MBC,ug ml-1,,0.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.6
26397,26397,,,6220690,[],CHEMBL1787231,Antibacterial activity against Mycobacterium intracellular ATCC 23068 by alamar blue method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,1,=,,IC50,ug.mL-1,,0.3,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,ug ml-1,UO_0000274,,0.3
26398,26398,,,6220691,[],CHEMBL1787231,Antibacterial activity against Mycobacterium intracellular ATCC 23068 by alamar blue method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,0.5
26399,26399,,,6222176,[],CHEMBL1787232,Ratio of cryptolepine IC50 to compound IC50 for Cryptococcus neoformans ATCC 90113,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1427364,=,1,0,=,,Ratio IC50,,,100.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,Ratio IC50,,,,100.0
26400,26400,,,6222207,[],CHEMBL1787233,Ratio of cryptolepine IC50 to compound IC50 for Candida albicans ATCC 90028,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781968,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1427364,=,1,0,=,,Ratio IC50,,,150.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,Ratio IC50,,,,150.0
26401,26401,,,6230608,[],CHEMBL1785958,Antibacterial activity against Bacillus subtilis at 5 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,6.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,cm,UO_0000016,,0.6
26402,26402,,,6230615,[],CHEMBL1785959,Antibacterial activity against Bacillus subtilis at 10 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,7.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,cm,UO_0000016,,0.7
26403,26403,,,6230629,[],CHEMBL1785960,Antibacterial activity against Bacillus subtilis at 15 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,9.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,cm,UO_0000016,,0.9
26404,26404,,,6230656,[],CHEMBL1785961,Antibacterial activity against Bacillus subtilis at 20 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,10.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,cm,UO_0000016,,1.0
26405,26405,,,6230668,[],CHEMBL1787696,Antibacterial activity against Pseudomonas aeruginosa at 5 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,12.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,cm,UO_0000016,,1.2
26406,26406,,,6230669,[],CHEMBL1785962,Antibacterial activity against Bacillus subtilis at 25 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,12.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,cm,UO_0000016,,1.2
26407,26407,,,6230684,[],CHEMBL1787691,Antibacterial activity against Escherichia coli at 5 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,14.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,cm,UO_0000016,,1.4
26408,26408,,,6230685,[],CHEMBL1787697,Antibacterial activity against Pseudomonas aeruginosa at 10 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,14.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,cm,UO_0000016,,1.4
26409,26409,,,6230686,[],CHEMBL1787706,Antibacterial activity against Salmonella typhi at 5 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,14.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,IZ,cm,UO_0000016,,1.4
26410,26410,,,6230711,[],CHEMBL1787692,Antibacterial activity against Escherichia coli at 10 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,cm,UO_0000016,,1.6
26411,26411,,,6230712,[],CHEMBL1787698,Antibacterial activity against Pseudomonas aeruginosa at 15 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,cm,UO_0000016,,1.6
26412,26412,,,6230713,[],CHEMBL1785831,Antibacterial activity against Salmonella typhi at 10 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,16.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,IZ,cm,UO_0000016,,1.6
26413,26413,,,6230733,[],CHEMBL1787693,Antibacterial activity against Escherichia coli at 15 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,18.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,cm,UO_0000016,,1.8
26414,26414,,,6230734,[],CHEMBL1785832,Antibacterial activity against Salmonella typhi at 15 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,18.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,IZ,cm,UO_0000016,,1.8
26415,26415,,,6230757,[],CHEMBL1787694,Antibacterial activity against Escherichia coli at 20 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,cm,UO_0000016,,2.0
26416,26416,,,6230758,[],CHEMBL1787699,Antibacterial activity against Pseudomonas aeruginosa at 20 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,20.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,cm,UO_0000016,,2.0
26417,26417,,,6230773,[],CHEMBL1787686,Antibacterial activity against Staphylococcus aureus at 5 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,cm,UO_0000016,,2.2
26418,26418,,,6230774,[],CHEMBL1785833,Antibacterial activity against Salmonella typhi at 20 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,22.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,IZ,cm,UO_0000016,,2.2
26419,26419,,,6230786,[],CHEMBL1787695,Antibacterial activity against Escherichia coli at 25 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,cm,UO_0000016,,2.3
26420,26420,,,6230787,[],CHEMBL1787700,Antibacterial activity against Pseudomonas aeruginosa at 25 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,23.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,cm,UO_0000016,,2.3
26421,26421,,,6231745,[],CHEMBL1787687,Antibacterial activity against Staphylococcus aureus at 10 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,cm,UO_0000016,,2.4
26422,26422,,,6231746,[],CHEMBL1787701,Antibacterial activity against Klebsiella pneumoniae at 5 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,24.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,cm,UO_0000016,,2.4
26423,26423,,,6231747,[],CHEMBL1785834,Antibacterial activity against Salmonella typhi at 25 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,24.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,IZ,cm,UO_0000016,,2.4
26424,26424,,,6231763,[],CHEMBL1787688,Antibacterial activity against Staphylococcus aureus at 15 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,cm,UO_0000016,,2.6
26425,26425,,,6231764,[],CHEMBL1787702,Antibacterial activity against Klebsiella pneumoniae at 10 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,26.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,cm,UO_0000016,,2.6
26426,26426,,,6231778,[],CHEMBL1787689,Antibacterial activity against Staphylococcus aureus at 20 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,cm,UO_0000016,,3.0
26427,26427,,,6231779,[],CHEMBL1787703,Antibacterial activity against Klebsiella pneumoniae at 15 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,30.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,cm,UO_0000016,,3.0
26428,26428,,,6231788,[],CHEMBL1787704,Antibacterial activity against Klebsiella pneumoniae at 20 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,34.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,cm,UO_0000016,,3.4
26429,26429,,,6231802,[],CHEMBL1787690,Antibacterial activity against Staphylococcus aureus at 25 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,36.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,cm,UO_0000016,,3.6
26430,26430,,,6231803,[],CHEMBL1787705,Antibacterial activity against Klebsiella pneumoniae at 25 ug after 24 hrs by disc diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1428184,=,1,1,=,,IZ,mm,,36.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,cm,UO_0000016,,3.6
26431,26431,,,6231812,[],CHEMBL1785966,Antibacterial activity against Staphylococcus aureus after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
26432,26432,,,6231821,[],CHEMBL1785966,Antibacterial activity against Staphylococcus aureus after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
26433,26433,,,6231830,[],CHEMBL1785967,Antibacterial activity against Escherichia coli after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.5
26434,26434,,,6231839,[],CHEMBL1785967,Antibacterial activity against Escherichia coli after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,1.0
26435,26435,,,6231848,[],CHEMBL1785968,Antibacterial activity against Klebsiella pneumoniae after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.5
26436,26436,,,6231857,[],CHEMBL1785968,Antibacterial activity against Klebsiella pneumoniae after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,1.0
26437,26437,,,6231866,[],CHEMBL1785969,Antibacterial activity against Pseudomonas aeruginosa after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,0.5
26438,26438,,,6231875,[],CHEMBL1785969,Antibacterial activity against Pseudomonas aeruginosa after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,1.0
26439,26439,,,6231884,[],CHEMBL1785970,Antibacterial activity against Salmonella typhi after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC50,ug ml-1,UO_0000274,,0.5
26440,26440,,,6231893,[],CHEMBL1785970,Antibacterial activity against Salmonella typhi after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC90,ug ml-1,UO_0000274,,1.0
26441,26441,,,6231902,[],CHEMBL1785971,Antibacterial activity against Bacillus subtilis after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC50,ug ml-1,UO_0000274,,0.5
26442,26442,,,6231911,[],CHEMBL1785971,Antibacterial activity against Bacillus subtilis after 18 to 20 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1428184,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC90,ug ml-1,UO_0000274,,1.0
26443,26443,,Active,6231913,[],CHEMBL1785963,Inhibition of Escherichia coli DNA gyrase assessed as inhibition of DNA supercoiling activity using pBR322 DNA as substrate at 1 to 100 mM after 3 hrs by agarose gel electrophoresis,B,,,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1428184,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
26444,26444,,Active,6231922,[],CHEMBL1785964,Inhibition of Escherichia coli DNA gyrase -mediated DNA relaxation using pBR322 DNA as substrate at 0.1 to 5 mM after 1 hrs by agarose gel electrophoresis,B,,,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781873,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1428184,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
26445,26445,,,6232294,[],CHEMBL1786523,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781906,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427813,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
26446,26446,,,6232323,[],CHEMBL1786524,Antibacterial activity against Streptococcus pyogenes after 18 to 24 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781906,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427813,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.4
26447,26447,,,6232352,[],CHEMBL1786525,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1781906,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427813,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
26448,26448,,,6255817,[],CHEMBL1799582,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795295,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1438619,=,1,1,=,,MIC,nM,,4700.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.7
26449,26449,,,6261040,[],CHEMBL1799080,Antibacterial activity against Bacillus subtilis BD54 after 16 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795271,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436868,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.078
26450,26450,,,6261041,[],CHEMBL1799073,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795271,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436868,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.156
26451,26451,,,6261042,[],CHEMBL1799074,Antibacterial activity against Staphylococcus aureus ATCC 13709 (Smith) after 16 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795271,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436868,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.078
26452,26452,,,6261043,[],CHEMBL1799075,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 1094 after 16 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795271,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436868,>,1,1,>,,MIC,ug.mL-1,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,20.0
26453,26453,,,6261044,[],CHEMBL1799076,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 16 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795271,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436868,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.625
26454,26454,,,6261045,[],CHEMBL1799077,Antibacterial activity against Enterococcus faecium ATCC 19434 after 16 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795271,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436868,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,5.0
26455,26455,,,6261046,[],CHEMBL1799078,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 16 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795271,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436868,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,20.0
26456,26456,,,6261047,[],CHEMBL1799079,Antibacterial activity against Escherichia coli J-53 after 16 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795271,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436868,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.313
26457,26457,,,6264500,[],CHEMBL1798360,Antimicrobial activity against Bacillus subtilis after 24 hrs by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795268,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435985,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,5.0
26458,26458,,,6264509,[],CHEMBL1798361,Antimicrobial activity against Staphylococcus aureus after 24 hrs by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795268,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435985,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
26459,26459,,,6264518,[],CHEMBL1798362,Antimicrobial activity against Vibrio cholerae after 24 hrs by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795268,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435985,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
26460,26460,,,6264527,[],CHEMBL1798363,Antimicrobial activity against Escherichia coli after 24 hrs by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795268,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435985,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.0
26461,26461,,,6264536,[],CHEMBL1798364,Antimicrobial activity against Proteus vulgaris after 24 hrs by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1795268,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1435985,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,10.0
26462,26462,,,6288676,[],CHEMBL1811131,Antibacterial activity against Staphylococcus aureus assessed as zone of inhibition at 100 ug/ml by agar plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1442935,=,1,1,=,,IZ,mm,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,25.0
26463,26463,,,6288677,[],CHEMBL1811132,Antibacterial activity against Staphylococcus epidermidis assessed as zone of inhibition at 100 ug/ml by agar plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1442935,=,1,1,=,,IZ,mm,,35.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,IZ,mm,UO_0000016,,35.0
26464,26464,,,6288678,[],CHEMBL1811133,Antibacterial activity against Bacillus subtilis assessed as zone of inhibition at 100 ug/ml by agar plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1442935,=,1,1,=,,IZ,mm,,33.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,33.0
26465,26465,,,6288679,[],CHEMBL1811134,Antibacterial activity against Escherichia coli assessed as zone of inhibition at 100 ug/ml by agar plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1442935,=,1,1,=,,IZ,mm,,35.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,35.0
26466,26466,,,6288680,[],CHEMBL1811135,Antibacterial activity against Klebsiella pneumoniae assessed as zone of inhibition at 100 ug/ml by agar plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1442935,=,1,1,=,,IZ,mm,,12.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,12.0
26467,26467,,,6288681,[],CHEMBL1811136,Antibacterial activity against Pseudomonas aeruginosa assessed as zone of inhibition at 100 ug/ml by agar plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1442935,=,1,1,=,,IZ,mm,,38.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,38.0
26468,26468,,Not Active,6288712,[],CHEMBL1811140,Antibacterial activity against Staphylococcus epidermidis assessed as zone of inhibition at 50 ug/ml by agar plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1442935,,1,0,,,Activity,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,,,,
26469,26469,,Not Active,6288713,[],CHEMBL1811141,Antibacterial activity against Bacillus subtilis assessed as zone of inhibition at 50 ug/ml by agar plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1442935,,1,0,,,Activity,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,,,,
26470,26470,,Not Active,6288714,[],CHEMBL1811142,Antibacterial activity against Escherichia coli assessed as zone of inhibition at 50 ug/ml by agar plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1442935,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
26471,26471,,Not Active,6288715,[],CHEMBL1811143,Antibacterial activity against Klebsiella pneumoniae assessed as zone of inhibition at 50 ug/ml by agar plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806360,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1442935,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
26472,26472,,,6289022,[],CHEMBL1811215,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
26473,26473,,,6289023,[],CHEMBL1811216,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
26474,26474,,,6289032,[],CHEMBL1811306,Antibacterial activity against Streptococcus pyogenes ATCC 19615,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
26475,26475,,,6289036,[],CHEMBL1811307,Antibacterial activity against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
26476,26476,,,6289041,[],CHEMBL1811308,Antibacterial activity against Enterococcus faecium ATCC 19434,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
26477,26477,,,6289047,[],CHEMBL1811309,Antibacterial activity against Streptococcus pneumoniae ATCC 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
26478,26478,,,6289048,[],CHEMBL1811310,Antibacterial activity against Haemophilus influenzae ATCC 49766,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.12
26479,26479,,,6289053,[],CHEMBL1811311,Antibacterial activity against Citrobacter freundii ATCC 8090,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.12
26480,26480,,,6289058,[],CHEMBL1811312,Antibacterial activity against Enterobacter cloacae ATCC 13047,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.12
26481,26481,,,6289063,[],CHEMBL1811313,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
26482,26482,,,6289072,[],CHEMBL1811489,Antibacterial activity against Propionibacterium acnes ATCC 11827,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.25
26483,26483,,,6289077,[],CHEMBL1811490,Antibacterial activity against Bacteroides fragilis ATCC 25285,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,4.0
26484,26484,,,6289081,[],CHEMBL1811491,Antifungal activity against Candida albicans ATCC 90028,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806384,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444465,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,64.0
26485,26485,,,6296497,[],CHEMBL1809936,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806424,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444619,=,1,1,=,,MIC,ug.mL-1,,15.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,15.0
26486,26486,,,6296522,[],CHEMBL1809934,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806424,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444619,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
26487,26487,,,6296525,[],CHEMBL1809935,Antibacterial activity against Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806424,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444619,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,25.0
26488,26488,,,6296528,[],CHEMBL1809937,Antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806424,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444619,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,25.0
26489,26489,,,6300739,[],CHEMBL1811600,Antibacterial activity against Escherichia coli KD65,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443958,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.04
26490,26490,,,6300751,[],CHEMBL1811601,Antibacterial activity against tolC knockout Escherichia coli KD1397,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443958,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
26491,26491,,,6300763,[],CHEMBL1811602,Antibacterial activity against Mycobacterium smegmatis KD1163,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443958,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.156
26492,26492,,,6318889,[],CHEMBL1815790,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 at 5 ug/disk after 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1811775,J Nat Prod,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1448281,=,1,1,=,,IZ,mm,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,8.0
26493,26493,,,6320361,[],CHEMBL1817149,Antibacterial activity against wild-type Staphylococcus aureus ATCC 25923 by M7-A7 CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1811797,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449624,=,1,1,=,,MIC,ug.mL-1,,0.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.31
26494,26494,,,6320368,[],CHEMBL1817242,Antibacterial activity against Staphylococcus aureus K1902 bearing norA-deficient mutation by M7-A7 CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1811797,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449624,=,1,1,=,,MIC,ug.mL-1,,0.63,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.63
26495,26495,,,6320375,[],CHEMBL1817243,Antibacterial activity against Staphylococcus aureus K2378 bearing norA++ efficient mutation by M7-A7 CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1811797,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449624,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.5
26496,26496,,,6320382,[],CHEMBL1817244,Antibacterial activity against wild-type norA expressing Staphylococcus aureus 1199 by M7-A7 CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1811797,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449624,=,1,1,=,,MIC,ug.mL-1,,0.63,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.63
26497,26497,,,6320389,[],CHEMBL1817245,Antibacterial activity against Staphylococcus aureus 1199B norA++ and A116E GrlA mutation by M7-A7 CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1811797,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449624,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
26498,26498,,,6325299,[],CHEMBL1819972,Antibacterial activity against Staphylococcus aureus subsp. aureus MTCC 1430 after 24 hrs by NCCLS M7-A6 serial dilution method,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1817581,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1449879,=,1,0,=,,-logMIC,,,3.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,3.16
26499,26499,,,6325300,[],CHEMBL1819973,Antibacterial activity against Bacillus subtilis MTCC 2423 Serovar 3 after 24 hrs by NCCLS M7-A6 serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1817581,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1449879,=,1,0,=,,-logMIC,,,3.16,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,3.16
26500,26500,,,6325301,[],CHEMBL1819974,Antibacterial activity against Escherichia coli MTCC 739 after 24 hrs by NCCLS M7-A6 serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1817581,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1449879,=,1,0,=,,-logMIC,,,3.52,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,3.52
26501,26501,,,6330157,[],CHEMBL1820646,Antimycobacterial activity against active log phase Mycobacterium smegmatis ATCC 14468 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1817660,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1450546,=,1,1,=,,MIC,nM,,4710.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,4.71
26502,26502,,Not Determined,6330158,[],CHEMBL1820647,Antimycobacterial activity against active log phase Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1817660,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1450546,,1,0,,,MIC,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,,,,
26503,26503,,,6330159,[],CHEMBL1820648,Antimycobacterial activity against 6-weeks nutrient starved phase cultures of Mycobacterium smegmatis ATCC 14468 treated for 7 days measured after 4 weeks by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1817660,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1450546,=,1,1,=,,MIC,nM,,2350.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,2.35
26504,26504,,Not Determined,6330160,[],CHEMBL1820649,Antimycobacterial activity against 6-weeks nutrient starved phase cultures of Mycobacterium tuberculosis H37Rv treated for 7 days measured after 4 weeks by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1817660,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1450546,,1,0,,,MIC,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,,,,
26505,26505,,,6342383,[],CHEMBL1826808,Antimicrobial activity against Escherichia coli BW25113 delta tolC after 14 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1821659,ACS Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1456097,=,1,1,=,,MIC,nM,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,nM,UO_0000065,,5.0
26506,26506,,,6343393,[],CHEMBL1827130,Inhibition of Escherichia coli DNA gyrase assessed as DNA supercoiling using pUC19 as substrate after 30 mins by agarose gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1821659,ACS Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.16,0,http://www.openphacts.org/units/Nanomolar,1456097,=,1,1,=,,IC50,nM,,700.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.7
26507,26507,,Active,6343394,[],CHEMBL1827131,Induction of DNA damage at Escherichia coli supercoiled pUC19 bound to DNA gyrase assessed as dsDNA breaks in the absence of ATP after 1 hrs by agarose gel electrophoresis,B,,,BAO_0000375,BAO_0000225,nucleic acid format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1821659,ACS Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1456097,,1,0,,,Activity,,,,CHEMBL345,,Nucleic Acid,,,,Activity,,,,
26508,26508,,,6345106,[],CHEMBL1827088,Antibacterial activity against Staphylococcus aureus ATCC 2937 after 24 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1821658,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1453626,=,1,1,=,,MIC90,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,10.0
26509,26509,,,6345141,[],CHEMBL1827087,Antibacterial activity against Bacillus subtilis ATCC 12711 after 24 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1821658,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1453626,=,1,1,=,,MIC90,ug.mL-1,,12.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC90,ug ml-1,UO_0000274,,12.5
26510,26510,,,6345176,[],CHEMBL1827086,Antibacterial activity against Escherichia coli ATCC 8739 after 24 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1821658,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1453626,=,1,1,=,,MIC90,ug.mL-1,,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,12.5
26511,26511,,,6346142,[],CHEMBL1826963,Antibacterial activity against Klebsiella pneumoniae ATCC 31488 after 24 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1821658,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1453626,=,1,1,=,,MIC90,ug.mL-1,,2.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,2.5
26512,26512,,,6346177,[],CHEMBL1826962,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth micro dilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1821658,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1453626,=,1,1,=,,MIC90,ug.mL-1,,1.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,1.25
26513,26513,,,6361216,[],CHEMBL1833552,Antitubercular activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828595,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1459666,=,1,1,=,,MIC,nM,,4700.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.7
26514,26514,,Active,6362111,[],CHEMBL1831573,Inhibition of Escherichia coli topoisomerase 4 assessed as decatenation of kDNA at 25 uM after 30 mins by electrophoresis,B,,,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828603,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1459864,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
26515,26515,,Active,6362117,[],CHEMBL1831576,Inhibition of Escherichia coli DNA gyrase supercoiling activity using pHOT1 DNA as substrate at 1 to 125 uM after 60 mins by agarose gel electrophoretic analysis,B,,,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828603,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1459864,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
26516,26516,,Active,6362118,[],CHEMBL1831513,Inhibition of Staphylococcus aureus topoisomerase 4-mediated relaxation of supercoiled pBR322 DNA at 1 uM after 30 mins by agarose gel electrophoretic analysis,B,,,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828603,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1459864,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
26517,26517,,Not Active,6362120,[],CHEMBL1831512,Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pHOT1 DNA as substrate at 125 uM after 60 mins by agarose gel electrophoretic analysis,B,,,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828603,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1459864,,1,0,,,Inhibition,%,,,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,INH,,UO_0000187,,
26518,26518,,,6365118,[],CHEMBL1832574,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 to 48 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828503,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1459721,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
26519,26519,,,6365146,[],CHEMBL1832575,Antimicrobial activity against Streptococcus pyogenes clinical isolate after 18 to 48 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828503,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1459721,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.4
26520,26520,,,6365791,[],CHEMBL1832576,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 48 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828503,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1459721,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
26521,26521,,,6365819,[],CHEMBL1832577,Antimicrobial activity against Klebsiella pneumoniae clinical isolate after 18 to 48 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828503,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1459721,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
26522,26522,,,6365845,[],CHEMBL1832578,Antimicrobial activity against Escherichia coli ATCC 25922 after 18 to 48 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828503,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1459721,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
26523,26523,,,6366574,[],CHEMBL1833489,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by colony forming unit determination,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457381,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
26524,26524,,,6366592,[],CHEMBL1833490,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis A8 241 after 28 days by colony forming unit determination,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457381,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.5
26525,26525,,,6366610,[],CHEMBL1833491,"Selectivity index, ratio of IC50 for human HepG2 cells to MIC for Mycobacterium tuberculosis H37Rv ATCC 27294",F,,,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1457381,=,1,0,=,,Selectivity Index,,,333.33,CHEMBL612545,,Unchecked,,,,Selectivity Index,,,,333.33
26526,26526,,,6366628,[],CHEMBL1833492,"Selectivity index, ratio of IC50 for human HepG2 cells to MIC for multidrug-resistant Mycobacterium tuberculosis A8 241",F,,,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1457381,=,1,0,=,,Selectivity Index,,,110.37,CHEMBL612545,,Unchecked,,,,Selectivity Index,,,,110.37
26527,26527,,,6366646,[],CHEMBL1833493,Antimycobacterial activity against Mycobacterium avium CNTC 330/88 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,=,1,1,=,,MIC,nM,,62500.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,umol/L,UO_0000065,,62.5
26528,26528,,,6366665,[],CHEMBL1833494,Antimycobacterial activity against Mycobacterium avium CNTC 330/88 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,=,1,1,=,,MIC,nM,,62500.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,umol/L,UO_0000065,,62.5
26529,26529,,,6367358,[],CHEMBL1833495,Antimycobacterial activity against Mycobacterium kansasii CNTC My 235/80 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,=,1,1,=,,MIC,nM,,1000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,1.0
26530,26530,,,6367377,[],CHEMBL1833496,Antimycobacterial activity against Mycobacterium kansasii CNTC My 235/80 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,=,1,1,=,,MIC,nM,,2000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,2.0
26531,26531,,,6367396,[],CHEMBL1833497,Antimycobacterial activity against Mycobacterium kansasii CNTC My 235/80 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,=,1,1,=,,MIC,nM,,2000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,2.0
26532,26532,,,6367415,[],CHEMBL1833498,Antimycobacterial activity against Mycobacterium kansasii CNTC 6509/96 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,=,1,1,=,,MIC,nM,,1000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,1.0
26533,26533,,,6367434,[],CHEMBL1833499,Antimycobacterial activity against Mycobacterium kansasii CNTC 6509/96 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,=,1,1,=,,MIC,nM,,1000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,1.0
26534,26534,,,6367453,[],CHEMBL1833500,Antimycobacterial activity against Mycobacterium kansasii CNTC 6509/96 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,=,1,1,=,,MIC,nM,,2000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,2.0
26535,26535,,,6367471,[],CHEMBL1833501,Cytotoxicity against human HepG2 cells measured after overnight incubation by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,>,1,1,>,,IC50,nM,,500000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,mmol/L,UO_0000065,,0.5
26536,26536,,,6367488,[],CHEMBL1833502,Cytotoxicity against human PBMC measured after overnight incubation by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,>,1,1,>,,IC50,nM,,500000.0,CHEMBL613107,Homo sapiens,PBMC,9606.0,,,IC50,mmol/L,UO_0000065,,0.5
26537,26537,,,6367505,[],CHEMBL1833503,Cytotoxicity against human SH-SY5Y cells measured after overnight incubation by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457381,>,1,1,>,,IC50,nM,,500000.0,CHEMBL614910,Homo sapiens,SH-SY5Y,9606.0,,,IC50,mmol/L,UO_0000065,,0.5
26538,26538,,,6367535,[],CHEMBL1831399,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis H37Rv after 28 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828510,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1457549,=,1,1,=,,MIC,nM,,4700.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.7
26539,26539,,,6369559,[],CHEMBL1832676,Antibacterial activity against 10'5 CFU/mL Staphylococcus aureus MTCC 96 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458182,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
26540,26540,,,6369561,[],CHEMBL1832678,Antibacterial activity against 10'5 CFU/mL Bacillus cereus MTCC 619 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458182,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,1.0
26541,26541,,,6369563,[],CHEMBL1832950,Antibacterial activity against 10'5 CFU/mL Escherichia coli MTCC 739 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458182,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
26542,26542,,,6369564,[],CHEMBL1832909,Antibacterial activity against 10'5 CFU/mL Shigella flexneri MTCC 1457 at 100 ug/ml after 24 hrs by disc diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458182,=,1,1,=,,IZ,mm,,32.0,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,IZ,mm,UO_0000016,,32.0
26543,26543,,,6369565,[],CHEMBL1832952,Antibacterial activity against 10'5 CFU/mL Pseudomonas aeruginosa MTCC 741 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458182,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
26544,26544,,,6369566,[],CHEMBL1832908,Antibacterial activity against 10'5 CFU/mL Proteus vulgaris MTCC 1771 at 100 ug/ml after 24 hrs by disc diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458182,=,1,1,=,,IZ,mm,,31.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,IZ,mm,UO_0000016,,31.0
26545,26545,,,6369567,[],CHEMBL1832954,Antibacterial activity against 10'5 CFU/mL Klebsiella pneumoniae MTCC 109 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458182,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
26546,26546,,,6369568,[],CHEMBL1832907,Antibacterial activity against 10'5 CFU/mL Salmonella typhi MTCC 733 at 100 ug/ml after 24 hrs by disc diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458182,=,1,1,=,,IZ,mm,,30.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,IZ,mm,UO_0000016,,30.0
26547,26547,,,6369569,[],CHEMBL1832956,Antibacterial activity against 10'5 CFU/mL Salmonella typhi MTCC 733 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458182,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,1.0
26548,26548,,,6369570,[],CHEMBL1832906,Antibacterial activity against 10'5 CFU/mL Klebsiella pneumoniae MTCC 109 at 100 ug/ml after 24 hrs by disc diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458182,=,1,1,=,,IZ,mm,,33.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,33.0
26549,26549,,,6369571,[],CHEMBL1832958,Antibacterial activity against 10'5 CFU/mL Proteus vulgaris MTCC 1771 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458182,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,1.0
26550,26550,,,6369572,[],CHEMBL1832960,Antibacterial activity against 10'5 CFU/mL Shigella flexneri MTCC 1457 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458182,<=,1,1,<=,,MIC,ug.mL-1,,3.0,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC,ug ml-1,UO_0000274,,3.0
26551,26551,,,6369659,[],CHEMBL1832904,Antibacterial activity against 10'5 CFU/mL Escherichia coli MTCC 739 at 100 ug/ml after 24 hrs by disc diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458182,=,1,1,=,,IZ,mm,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,32.0
26552,26552,,,6369660,[],CHEMBL1832905,Antibacterial activity against 10'5 CFU/mL Pseudomonas aeruginosa MTCC 741 at 100 ug/ml after 24 hrs by disc diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458182,=,1,1,=,,IZ,mm,,33.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,33.0
26553,26553,,,6369661,[],CHEMBL1832903,Antibacterial activity against 10'5 CFU/mL Bacillus cereus MTCC 619 at 100 ug/ml after 24 hrs by disc diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458182,=,1,1,=,,IZ,mm,,31.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,IZ,mm,UO_0000016,,31.0
26554,26554,,,6369662,[],CHEMBL1832902,Antibacterial activity against 10'5 CFU/mL Staphylococcus aureus MTCC 96 at 100 ug/ml after 24 hrs by disc diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828552,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458182,=,1,1,=,,IZ,mm,,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,30.0
26555,26555,,,6370132,[],CHEMBL1833511,Antibacterial activity against Staphylococcus aureus MTCC 96 at 2 mg/ml after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828500,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458453,=,1,1,=,,IZ,mm,,26.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,26.6
26556,26556,,,6370157,[],CHEMBL1833512,Antibacterial activity against Bacillus subtilis MTCC 121 at 2 mg/ml after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828500,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458453,=,1,1,=,,IZ,mm,,24.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,24.0
26557,26557,,,6370182,[],CHEMBL1833513,Antibacterial activity against Escherichia coli MTCC 1652 at 2 mg/ml after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828500,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458453,=,1,1,=,,IZ,mm,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,25.0
26558,26558,,,6370207,[],CHEMBL1833514,Antibacterial activity against Pseudomonas aeruginosa MTCC 741 at 2 mg/ml after 24 hrs by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828500,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1458453,=,1,1,=,,IZ,mm,,22.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,22.0
26559,26559,,,6370232,[],CHEMBL1833515,Antibacterial activity against Staphylococcus aureus MTCC 96 after 24 hrs by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828500,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458453,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
26560,26560,,,6370257,[],CHEMBL1833516,Antibacterial activity against Bacillus subtilis MTCC 121 after 24 hrs by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828500,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458453,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,5.0
26561,26561,,,6370282,[],CHEMBL1833517,Antibacterial activity against Escherichia coli MTCC 1652 after 24 hrs by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828500,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458453,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.0
26562,26562,,,6370307,[],CHEMBL1833518,Antibacterial activity against Pseudomonas aeruginosa MTCC 741 after 24 hrs by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1828500,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1458453,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,5.0
26563,26563,,,6375857,[],CHEMBL1839988,Antibacterial activity against 10'8 CFU/mL Bacillus subtilis MTCC 441 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460742,=,1,0,=,,MIC99,ug ml-1,,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC99,ug ml-1,UO_0000274,,50.0
26564,26564,,,6375874,[],CHEMBL1839989,Antibacterial activity against 10'8 CFU/mL Streptococcus pyogenes MTCC 442 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460742,=,1,0,=,,MIC99,ug ml-1,,50.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC99,ug ml-1,UO_0000274,,50.0
26565,26565,,,6375891,[],CHEMBL1839990,Antibacterial activity against 10'8 CFU/mL Staphylococcus aureus MTCC 96 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460742,=,1,0,=,,MIC99,ug ml-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC99,ug ml-1,UO_0000274,,50.0
26566,26566,,,6375908,[],CHEMBL1839991,Antibacterial activity against 10'8 CFU/mL Salmonella typhi MTCC 98 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460742,=,1,0,=,,MIC99,ug ml-1,,25.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC99,ug ml-1,UO_0000274,,25.0
26567,26567,,,6375925,[],CHEMBL1839992,Antibacterial activity against 10'8 CFU/mL Klebsiella pneumoniae MTCC 109 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460742,=,1,0,=,,MIC99,ug ml-1,,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC99,ug ml-1,UO_0000274,,25.0
26568,26568,,,6375942,[],CHEMBL1839994,Antibacterial activity against 10'8 CFU/mL Pseudomonas aeruginosa MTCC 1688 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460742,=,1,0,=,,MIC99,ug ml-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC99,ug ml-1,UO_0000274,,25.0
26569,26569,,,6375959,[],CHEMBL1839993,Antibacterial activity against 10'8 CFU/mL Escherichia coli MTCC 443 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460742,=,1,0,=,,MIC99,ug ml-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC99,ug ml-1,UO_0000274,,25.0
26570,26570,,,6377129,[],CHEMBL1838715,Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.25
26571,26571,,,6377140,[],CHEMBL1838890,Antibacterial activity against Escherichia coli 700 expressing TolC after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
26572,26572,,,6377151,[],CHEMBL1838891,Antibacterial activity against TolC deficient Escherichia coli 701 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
26573,26573,,,6377162,[],CHEMBL1838892,Antibacterial activity against Pseudomonas aeruginosa PAO1 ATCC BAA-47 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.313
26574,26574,,,6377173,[],CHEMBL1838893,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring oprM deltamexAB after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.02
26575,26575,,,6377184,[],CHEMBL1838894,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13637 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,0.156
26576,26576,,,6377195,[],CHEMBL1838895,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.313
26577,26577,,,6377206,[],CHEMBL1838896,Antibacterial activity against Bacillus subtilis BD54 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.156
26578,26578,,,6377217,[],CHEMBL1838897,Antibacterial activity against Bacillus anthracis Sterne after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,ug ml-1,UO_0000274,,0.078
26579,26579,,,6377228,[],CHEMBL1838898,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.625
26580,26580,,,6377239,[],CHEMBL1838899,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1094 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,20.0
26581,26581,,,6377250,[],CHEMBL1838900,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.25
26582,26582,,,6377261,[],CHEMBL1838901,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.625
26583,26583,,,6377272,[],CHEMBL1838902,Antibacterial activity against Burkholderia cepacia ATCC 39277 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,0.078
26584,26584,,,6377283,[],CHEMBL1838903,Antibacterial activity against Burkholderia cepacia ATCC 55792 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,0.625
26585,26585,,,6377294,[],CHEMBL1838904,Antibacterial activity against Escherichia coli ATCC 29425 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,<,1,1,<,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
26586,26586,,,6377304,[],CHEMBL1838905,Antibacterial activity against Escherichia coli ATCC 29425 after 16 to 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,<,1,1,<,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
26587,26587,,,6377314,[],CHEMBL1838906,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 to 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
26588,26588,,,6377324,[],CHEMBL1838907,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 16 to 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
26589,26589,,,6377334,[],CHEMBL1838908,Antibacterial activity against Klebsiella pneumoniae ATCC 13882 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460421,=,1,1,=,,MIC,ug.mL-1,,0.039,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.039
26590,26590,,,6379945,[],CHEMBL1839543,Antimicrobial activity against Streptococcus pneumoniae MTCC 1936 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461482,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,50.0
26591,26591,,,6379973,[],CHEMBL1839544,Antimicrobial activity against Clostridium tetani MTCC 449 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461482,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,100.0
26592,26592,,,6380001,[],CHEMBL1839545,Antimicrobial activity against Bacillus subtilis MTCC 441 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461482,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,50.0
26593,26593,,,6380029,[],CHEMBL1839546,Antimicrobial activity against Salmonella typhi MTCC 98 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461482,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,25.0
26594,26594,,,6380057,[],CHEMBL1839547,Antimicrobial activity against Vibrio cholerae MTCC 3906 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461482,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,25.0
26595,26595,,,6380984,[],CHEMBL1839548,Antimicrobial activity against Escherichia coli MTCC 443 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461482,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
26596,26596,,,6387523,[],CHEMBL1840010,Antituberculosis activity against 10'7 cfu/mL Mycobacterium tuberculosis H37Rv after 28 days,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833855,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1460892,=,1,1,=,,MIC,nM,,4700.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.7
26597,26597,,,6387525,[],CHEMBL1840004,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by NCCLS M7-A5 based agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833855,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460892,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
26598,26598,,,6387527,[],CHEMBL1840006,Antibacterial activity against Staphylococcus aureus ATCC 11632 after 18 to 24 hrs by NCCLS M7-A5 based agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833855,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460892,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
26599,26599,,,6387650,[],CHEMBL1840012,Antibacterial activity against Staphylococcus aureus ATCC 11632 assessed as zone of inhibition at 10 ug/disc after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833855,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1460892,=,1,1,=,,IZ,mm,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,25.0
26600,26600,,,6387652,[],CHEMBL1840011,Antibacterial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 10 ug/disc after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1833855,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1460892,=,1,1,=,,IZ,mm,,28.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,28.0
26601,26601,,active,6685587,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1201862,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,978481,,7,1,,,Potency,nM,,1281.8,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,1.2818
26602,26602,,active,7286246,[],CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1201862,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,978481,,7,1,,,Potency,nM,,3612.5,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,3.6125
26603,26603,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680056,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,,,,
26604,26604,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680057,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,Ki,,,,
26605,26605,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680058,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,IC50,,,,
26606,26606,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680059,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,Ki,,,,
26607,26607,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680060,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,IC50,,,,
26608,26608,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680061,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,Ki,,,,
26609,26609,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680062,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,IC50,,,,
26610,26610,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680063,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,Ki,,,,
26611,26611,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680064,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26612,26612,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680065,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26613,26613,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680066,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,IC50,,,,
26614,26614,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680067,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,Ki,,,,
26615,26615,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680068,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,IC50,,,,
26616,26616,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680069,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,Ki,,,,
26617,26617,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680070,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,IC50,,,,
26618,26618,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680071,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,Ki,,,,
26619,26619,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680072,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,IC50,,,,
26620,26620,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680073,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,Ki,,,,
26621,26621,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680074,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,IC50,,,,
26622,26622,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680075,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,Ki,,,,
26623,26623,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680076,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,IC50,,,,
26624,26624,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680077,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,Ki,,,,
26625,26625,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680078,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,IC50,,,,
26626,26626,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680079,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,Ki,,,,
26627,26627,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680080,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,IC50,,,,
26628,26628,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680081,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,Ki,,,,
26629,26629,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680082,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,IC50,,,,
26630,26630,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680083,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,Ki,,,,
26631,26631,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680084,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,IC50,,,,
26632,26632,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680085,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,Ki,,,,
26633,26633,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680086,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,IC50,,,,
26634,26634,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680087,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,Ki,,,,
26635,26635,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680088,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,IC50,,,,
26636,26636,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680089,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,Ki,,,,
26637,26637,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680090,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26638,26638,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680091,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26639,26639,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680092,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26640,26640,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680093,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26641,26641,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680094,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26642,26642,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680095,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000192,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26643,26643,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680096,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,IC50,,,,
26644,26644,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680097,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,Ki,,,,
26645,26645,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680098,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,IC50,,,,
26646,26646,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680099,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,Ki,,,,
26647,26647,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680100,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26648,26648,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680101,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26649,26649,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680102,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26650,26650,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680103,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26651,26651,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680104,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26652,26652,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680105,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26653,26653,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680106,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,IC50,,,,
26654,26654,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680107,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,Ki,,,,
26655,26655,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680108,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,IC50,,,,
26656,26656,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680109,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,Ki,,,,
26657,26657,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680110,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,IC50,,,,
26658,26658,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680111,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,Ki,,,,
26659,26659,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680112,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,IC50,,,,
26660,26660,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680113,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,Ki,,,,
26661,26661,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680114,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,IC50,,,,
26662,26662,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680115,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,Ki,,,,
26663,26663,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680116,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,IC50,,,,
26664,26664,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680117,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,Ki,,,,
26665,26665,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680118,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,IC50,,,,
26666,26666,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680119,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,Ki,,,,
26667,26667,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680120,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,IC50,,,,
26668,26668,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680121,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,Ki,,,,
26669,26669,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680122,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,IC50,,,,
26670,26670,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680123,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,Ki,,,,
26671,26671,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680124,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,IC50,,,,
26672,26672,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680125,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,Ki,,,,
26673,26673,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680126,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,IC50,,,,
26674,26674,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680127,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Ki,,,,
26675,26675,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680128,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,IC50,,,,
26676,26676,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680129,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,Ki,,,,
26677,26677,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680130,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,IC50,,,,
26678,26678,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680131,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,Ki,,,,
26679,26679,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680132,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,IC50,,,,
26680,26680,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680133,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,Ki,,,,
26681,26681,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680134,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,IC50,,,,
26682,26682,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680135,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,Ki,,,,
26683,26683,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680136,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,IC50,,,,
26684,26684,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680137,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,Ki,,,,
26685,26685,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680138,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,,,,
26686,26686,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680139,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ki,,,,
26687,26687,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680140,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,IC50,,,,
26688,26688,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680141,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,Ki,,,,
26689,26689,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680142,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,IC50,,,,
26690,26690,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680143,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,Ki,,,,
26691,26691,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680144,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,IC50,,,,
26692,26692,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680145,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,Ki,,,,
26693,26693,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680146,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,IC50,,,,
26694,26694,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680147,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,Ki,,,,
26695,26695,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680148,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,IC50,,,,
26696,26696,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680149,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,Ki,,,,
26697,26697,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680150,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,IC50,,,,
26698,26698,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680151,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,Ki,,,,
26699,26699,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680152,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,IC50,,,,
26700,26700,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680153,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Ki,,,,
26701,26701,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680154,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,IC50,,,,
26702,26702,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680155,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,Ki,,,,
26703,26703,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680156,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26704,26704,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680157,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26705,26705,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680158,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26706,26706,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680159,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26707,26707,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682200,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26708,26708,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682201,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26709,26709,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682202,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,IC50,,,,
26710,26710,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682203,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,Ki,,,,
26711,26711,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682204,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26712,26712,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682205,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26713,26713,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682206,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26714,26714,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682207,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26715,26715,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682208,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26716,26716,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682209,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26717,26717,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682210,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26718,26718,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682211,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26719,26719,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682212,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,IC50,,,,
26720,26720,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682213,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,Ki,,,,
26721,26721,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682214,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,IC50,,,,
26722,26722,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682215,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,Ki,,,,
26723,26723,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682216,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,IC50,,,,
26724,26724,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682217,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,Ki,,,,
26725,26725,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682218,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,IC50,,,,
26726,26726,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682219,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,Ki,,,,
26727,26727,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682220,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26728,26728,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682221,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26729,26729,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682222,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,IC50,,,,
26730,26730,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682223,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,Ki,,,,
26731,26731,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682224,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26732,26732,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682225,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26733,26733,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682226,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26734,26734,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682227,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26735,26735,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682228,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,IC50,,,,
26736,26736,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682229,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,Ki,,,,
26737,26737,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682230,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,IC50,,,,
26738,26738,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682231,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,Ki,,,,
26739,26739,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682232,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,IC50,,,,
26740,26740,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682233,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,Ki,,,,
26741,26741,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682234,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,IC50,,,,
26742,26742,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682235,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,Ki,,,,
26743,26743,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682236,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,IC50,,,,
26744,26744,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682237,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,Ki,,,,
26745,26745,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682238,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,IC50,,,,
26746,26746,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682239,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,Ki,,,,
26747,26747,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682240,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,IC50,,,,
26748,26748,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682241,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,Ki,,,,
26749,26749,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682242,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,IC50,,,,
26750,26750,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682243,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,Ki,,,,
26751,26751,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682244,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,IC50,,,,
26752,26752,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682245,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,Ki,,,,
26753,26753,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682246,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,IC50,,,,
26754,26754,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682247,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,Ki,,,,
26755,26755,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682248,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,IC50,,,,
26756,26756,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682249,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,Ki,,,,
26757,26757,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682250,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,IC50,,,,
26758,26758,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682251,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,Ki,,,,
26759,26759,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682252,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,IC50,,,,
26760,26760,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682253,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,Ki,,,,
26761,26761,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682254,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,IC50,,,,
26762,26762,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682255,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,Ki,,,,
26763,26763,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682256,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26764,26764,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682257,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26765,26765,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682258,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,IC50,,,,
26766,26766,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682259,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,Ki,,,,
26767,26767,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682260,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,IC50,,,,
26768,26768,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682261,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,Ki,,,,
26769,26769,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682262,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,IC50,,,,
26770,26770,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682263,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,Ki,,,,
26771,26771,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682264,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,IC50,,,,
26772,26772,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682265,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,Ki,,,,
26773,26773,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682266,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,IC50,,,,
26774,26774,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682267,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,Ki,,,,
26775,26775,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682268,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26776,26776,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682269,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26777,26777,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682270,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26778,26778,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682271,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26779,26779,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682272,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26780,26780,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682273,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26781,26781,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682274,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,IC50,,,,
26782,26782,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682275,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,Ki,,,,
26783,26783,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682276,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,IC50,,,,
26784,26784,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682277,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,Ki,,,,
26785,26785,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682278,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26786,26786,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682279,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26787,26787,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682280,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26788,26788,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682281,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26789,26789,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682282,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,,,,
26790,26790,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682283,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,Ki,,,,
26791,26791,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682284,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,IC50,,,,
26792,26792,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682285,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,Ki,,,,
26793,26793,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682286,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,IC50,,,,
26794,26794,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682287,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,Ki,,,,
26795,26795,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682288,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,IC50,,,,
26796,26796,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682289,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,Ki,,,,
26797,26797,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682290,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,IC50,,,,
26798,26798,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682291,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,Ki,,,,
26799,26799,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682292,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,IC50,,,,
26800,26800,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682293,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,Ki,,,,
26801,26801,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682294,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,IC50,,,,
26802,26802,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682295,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,Ki,,,,
26803,26803,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682296,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,IC50,,,,
26804,26804,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682297,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,Ki,,,,
26805,26805,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682298,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,IC50,,,,
26806,26806,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682299,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,Ki,,,,
26807,26807,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682300,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,IC50,,,,
26808,26808,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682301,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,Ki,,,,
26809,26809,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682302,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,IC50,,,,
26810,26810,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682303,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,Ki,,,,
26811,26811,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682304,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,IC50,,,,
26812,26812,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682305,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,Ki,,,,
26813,26813,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682306,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,IC50,,,,
26814,26814,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682307,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,Ki,,,,
26815,26815,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682308,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,IC50,,,,
26816,26816,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682309,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,Ki,,,,
26817,26817,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682310,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,IC50,,,,
26818,26818,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682311,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,Ki,,,,
26819,26819,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682312,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,IC50,,,,
26820,26820,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682313,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,Ki,,,,
26821,26821,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682314,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,IC50,,,,
26822,26822,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682315,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,Ki,,,,
26823,26823,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682316,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,IC50,,,,
26824,26824,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682317,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,Ki,,,,
26825,26825,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682318,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26826,26826,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682319,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26827,26827,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682320,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,IC50,,,,
26828,26828,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682321,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,Ki,,,,
26829,26829,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682322,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,IC50,,,,
26830,26830,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682323,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,Ki,,,,
26831,26831,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682324,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,IC50,,,,
26832,26832,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682325,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,Ki,,,,
26833,26833,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682326,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,IC50,,,,
26834,26834,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682327,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,Ki,,,,
26835,26835,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682328,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,IC50,,,,
26836,26836,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682329,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,Ki,,,,
26837,26837,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682330,[],CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26838,26838,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684336,[],CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26839,26839,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684337,[],CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,,IC50,,,,
26840,26840,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684338,[],CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,,Ki,,,,
26841,26841,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684339,[],CHEMBL1909108,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,IC50,,,,
26842,26842,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684340,[],CHEMBL1909108,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,Ki,,,,
26843,26843,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684341,[],CHEMBL1909109,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,IC50,,,,
26844,26844,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684342,[],CHEMBL1909109,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,Ki,,,,
26845,26845,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684343,[],CHEMBL1909110,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL287,Homo sapiens,Sigma opioid receptor,9606.0,,,IC50,,,,
26846,26846,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684344,[],CHEMBL1909110,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL287,Homo sapiens,Sigma opioid receptor,9606.0,,,Ki,,,,
26847,26847,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684345,[],CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26848,26848,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684346,[],CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26849,26849,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684347,[],CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26850,26850,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684348,[],CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26851,26851,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684349,[],CHEMBL1909113,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,IC50,,,,
26852,26852,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684350,[],CHEMBL1909113,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,Ki,,,,
26853,26853,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684351,[],CHEMBL1909114,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL2327,Homo sapiens,Neurokinin 2 receptor,9606.0,,,IC50,,,,
26854,26854,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684352,[],CHEMBL1909114,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL2327,Homo sapiens,Neurokinin 2 receptor,9606.0,,,Ki,,,,
26855,26855,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684353,[],CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,IC50,,,,
26856,26856,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684354,[],CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,Ki,,,,
26857,26857,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684355,[],CHEMBL1909116,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1835,Homo sapiens,Thromboxane-A synthase,9606.0,,,IC50,,,,
26858,26858,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684356,[],CHEMBL1909116,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),B,,,BAO_0000192,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1835,Homo sapiens,Thromboxane-A synthase,9606.0,,,Ki,,,,
26859,26859,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684357,[],CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
26860,26860,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684358,[],CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
26861,26861,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684359,[],CHEMBL1909118,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1868,Homo sapiens,Vascular endothelial growth factor receptor 1,9606.0,,,IC50,,,,
26862,26862,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684360,[],CHEMBL1909118,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),B,,,BAO_0000192,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1868,Homo sapiens,Vascular endothelial growth factor receptor 1,9606.0,,,Ki,,,,
26863,26863,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684361,[],CHEMBL1909119,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL5144,Homo sapiens,Vasoactive intestinal polypeptide receptor 1,9606.0,,,IC50,,,,
26864,26864,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684362,[],CHEMBL1909119,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL5144,Homo sapiens,Vasoactive intestinal polypeptide receptor 1,9606.0,,,Ki,,,,
26865,26865,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684363,[],CHEMBL1909120,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,IC50,,,,
26866,26866,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684364,[],CHEMBL1909120,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),B,,,BAO_0000192,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,Ki,,,,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,Ki,,,,
26867,26867,,DILI severity category; acute liver failure,7829018,[],CHEMBL1909291,FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of most concern for DILI,T,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909281,Drug Discov Today,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1540296,=,1,0,=,,LTKB_BD DILI severity score,,,7.0,CHEMBL1697861,,Hepatotoxicity,,,,LTKB_BD DILI severity score,,,,7.0
26868,26868,,,7839083,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_bilirubinemia,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,1.0
26869,26869,,,7839084,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
26870,26870,,,7839085,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
26871,26871,,,7839086,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
26872,26872,,,7839087,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
26873,26873,,,7839088,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_hepatic failure,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,1.0
26874,26874,,,7839089,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_hepatic necrosis,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,1.0
26875,26875,,,7839090,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_hepatitis,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,1.0
26876,26876,,,7839091,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_hepatomegaly,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,1.0
26877,26877,,,7839092,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_jaundice,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,1.0
26878,26878,,,7839093,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
26879,26879,,,7839094,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
26880,26880,,,7839095,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_liver function tests abnormal,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,1.0
26881,26881,,,7839096,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1541104,=,1,0,=,,HepSE_Combined Scores,,,7.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,7.0
26882,26882,,,7842556,[],CHEMBL1913142,Antibacterial activity against Micrococcus luteus ATCC 9341 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,4.0
26883,26883,,,7842557,[],CHEMBL1913143,Antibacterial activity against Micrococcus luteus ATCC 10240 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
26884,26884,,,7842678,[],CHEMBL1913345,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by EUCAST broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909615,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1542678,<=,1,1,<=,,MIC,nM,,758.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/ml,UO_0000065,,0.000758
26885,26885,,,7842701,[],CHEMBL1913344,Antibacterial activity against Bacillus subtilis ATCC 10400 after 18 hrs by EUCAST broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909615,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1542678,<=,1,1,<=,,MIC,nM,,758.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,umol/ml,UO_0000065,,0.000758
26886,26886,,,7842724,[],CHEMBL1913346,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by EUCAST broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909615,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1542678,<=,1,1,<=,,MIC,nM,,758.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/ml,UO_0000065,,0.000758
26887,26887,,,7842747,[],CHEMBL1913347,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by EUCAST broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909615,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1542678,=,1,1,=,,MIC,nM,,758.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/ml,UO_0000065,,0.000758
26888,26888,,,7843690,[],CHEMBL1913345,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by EUCAST broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909615,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1542678,=,1,0,=,,-log(1/MIC),,,3.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-log(1/MIC),,,,3.12
26889,26889,,,7843713,[],CHEMBL1913344,Antibacterial activity against Bacillus subtilis ATCC 10400 after 18 hrs by EUCAST broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909615,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1542678,=,1,0,=,,-log(1/MIC),,,3.12,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-log(1/MIC),,,,3.12
26890,26890,,,7843736,[],CHEMBL1913346,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by EUCAST broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909615,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1542678,=,1,0,=,,-log(1/MIC),,,3.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-log(1/MIC),,,,3.12
26891,26891,,,7843759,[],CHEMBL1913347,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by EUCAST broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909615,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1542678,=,1,0,=,,-log(1/MIC),,,3.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,-log(1/MIC),,,,3.12
26892,26892,,,7844809,[],CHEMBL1912482,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by agar disk diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909519,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543429,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,12.5
26893,26893,,,7844822,[],CHEMBL1912481,Antibacterial activity against Escherichia coli after 24 hrs by agar disk diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909519,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543429,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,12.5
26894,26894,,,7844835,[],CHEMBL1912480,Antibacterial activity against Enterococcus faecalis after 24 hrs by agar disk diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909519,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543429,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,12.5
26895,26895,,,7844848,[],CHEMBL1912479,Antibacterial activity against Staphylococcus aureus after 24 hrs by agar disk diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909519,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543429,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
26896,26896,,,7844863,[],CHEMBL1912548,Antibacterial activity against Klebsiella pneumoniae at 30 ug/ml after 24 hrs by agar disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909519,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1543429,=,1,1,=,,IZ,mm,,30.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,DIZ,mm,UO_0000016,,30.0
26897,26897,,,7844864,[],CHEMBL1912547,Antibacterial activity against Escherichia coli at 30 ug/ml after 24 hrs by agar disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909519,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1543429,=,1,1,=,,IZ,mm,,27.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,27.0
26898,26898,,,7844865,[],CHEMBL1912546,Antibacterial activity against Enterococcus faecalis at 30 ug/ml after 24 hrs by agar disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909519,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1543429,=,1,1,=,,IZ,mm,,29.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,DIZ,mm,UO_0000016,,29.0
26899,26899,,,7844866,[],CHEMBL1912545,Antibacterial activity against Staphylococcus aureus at 30 ug/ml after 24 hrs by agar disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909519,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1543429,=,1,1,=,,IZ,mm,,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,28.0
26900,26900,,,7849753,[],CHEMBL1913515,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 25 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909590,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543906,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
26901,26901,,,7849754,[],CHEMBL1913516,Antibacterial activity against Streptococcus pyogenes clinical isolate after 18 to 25 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909590,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543906,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.4
26902,26902,,,7849755,[],CHEMBL1913517,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 25 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909590,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543906,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
26903,26903,,,7849756,[],CHEMBL1913518,Antibacterial activity against Klebsiella pneumoniae clinical isolates after 18 to 25 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909590,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543906,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
26904,26904,,,7849757,[],CHEMBL1913519,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 25 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909590,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1543906,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
26905,26905,,,7856177,[],CHEMBL1913141,Antibacterial activity against Bacillus cereus ATCC 11778 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,1.0
26906,26906,,,7856178,[],CHEMBL1913140,Antibacterial activity against Bacillus subtilis ATCC 6633 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.125
26907,26907,,,7856179,[],CHEMBL1913139,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
26908,26908,,,7856180,[],CHEMBL1913138,Antibacterial activity against Staphylococcus aureus NCTC 4163 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
26909,26909,,,7856181,[],CHEMBL1913137,Antibacterial activity against Staphylococcus aureus ATCC 29213 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
26910,26910,,,7856182,[],CHEMBL1913136,Antibacterial activity against Staphylococcus aureus ATCC 6538 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
26911,26911,,,7856183,[],CHEMBL1913135,Antibacterial activity against Staphylococcus aureus ATCC 25923 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909494,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1542411,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
26912,26912,,,7934290,[],CHEMBL1920729,Antimicrobial activity against Staphylococcus aureus SG511 assessed after 18 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1559523,=,1,1,=,,MIC90,nM,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,uM,UO_0000065,,0.5
26913,26913,,,7934291,[],CHEMBL1920730,Antimicrobial activity against Enterococcus faecalis ATCC 49532 assessed after 18 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1559523,=,1,1,=,,MIC90,nM,,2000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,uM,UO_0000065,,2.0
26914,26914,,,7935673,[],CHEMBL1919492,Antimycobacterial activity Mycobacterium tuberculosis H37Rv after 6 days by MTT colorimetric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914444,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1556716,=,1,1,=,,MIC,nM,,2500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,2.5
26915,26915,,,7935913,[],CHEMBL1920732,Antimicrobial activity against Micrococcus luteus ATCC 10240 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,<=,1,1,<=,,IZ,mm,,10.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,DIZ,mm,UO_0000016,,10.0
26916,26916,,,7935914,[],CHEMBL1920733,Antimicrobial activity against Staphylococcus aureus SG511 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,21.0
26917,26917,,,7935915,[],CHEMBL1920734,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 134/94 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,=,1,1,=,,IZ,mm,,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,11.0
26918,26918,,,7935916,[],CHEMBL1920735,Antimicrobial activity against Enterococcus faecalis ATCC 49532 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,=,1,1,=,,IZ,mm,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,DIZ,mm,UO_0000016,,16.0
26919,26919,,,7935917,[],CHEMBL1920736,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis 1528 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,=,1,1,=,,IZ,mm,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,DIZ,mm,UO_0000016,,16.0
26920,26920,,,7935918,[],CHEMBL1920737,Antimicrobial activity against Bacillus subtilis ATCC 6633 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,21.0
26921,26921,,,7935919,[],CHEMBL1920839,Antimicrobial activity against Mycobacterium vaccae IMET 10670 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,,DIZ,mm,UO_0000016,,21.0
26922,26922,,,7935920,[],CHEMBL1920840,Antimicrobial activity against Escherichia coli DC0 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,21.0
26923,26923,,,7935921,[],CHEMBL1920841,Antimicrobial activity against Escherichia coli DC2 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,21.0
26924,26924,,,7935922,[],CHEMBL1920842,Antimicrobial activity against Pseudomonas aeruginosa 799/WT at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,21.0
26925,26925,,,7935923,[],CHEMBL1920843,Antimicrobial activity against Pseudomonas aeruginosa 799/61 at 5 ug/ml after 24 hrs by Kirby-Bauer agar diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914331,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1559523,>=,1,1,>=,,IZ,mm,,21.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,21.0
26926,26926,,,7940260,[],CHEMBL1921192,Antimicrobial activity against Staphylococcus aureus CIP 4.83 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,<=,1,1,<=,,MIC,nM,,970.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.97
26927,26927,,,7940322,[],CHEMBL1921192,Antimicrobial activity against Staphylococcus aureus CIP 4.83 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1557678,<=,1,0,<=,,MBC,uM,,0.97,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM,UO_0000064,,0.97
26928,26928,,,7940384,[],CHEMBL1921193,Antimicrobial activity against Enterococcus hirae CIP 5855 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,<=,1,1,<=,,MIC,nM,,970.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,,MIC,uM,UO_0000065,,0.97
26929,26929,,,7940446,[],CHEMBL1921193,Antimicrobial activity against Enterococcus hirae CIP 5855 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1557678,=,1,0,=,,MBC,uM,,1.9,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,,MBC,uM,UO_0000064,,1.9
26930,26930,,,7940508,[],CHEMBL1921194,Antimicrobial activity against Pseudomonas aeruginosa CIP 82.118 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,<=,1,1,<=,,MIC,nM,,970.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,0.97
26931,26931,,,7940858,[],CHEMBL1921194,Antimicrobial activity against Pseudomonas aeruginosa CIP 82.118 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1557678,<=,1,0,<=,,MBC,uM,,0.97,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,uM,UO_0000064,,0.97
26932,26932,,,7940920,[],CHEMBL1921195,Antimicrobial activity against Escherichia coli CIP 53126 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,<=,1,1,<=,,MIC,nM,,970.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.97
26933,26933,,,7940982,[],CHEMBL1921195,Antimicrobial activity against Escherichia coli CIP 53126 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1557678,<=,1,0,<=,,MBC,uM,,0.97,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,uM,UO_0000064,,0.97
26934,26934,,,7941044,[],CHEMBL1921196,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT colorimetric microassay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,=,1,1,=,,MIC,nM,,2500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,2.5
26935,26935,,,7941057,[],CHEMBL1921196,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT colorimetric microassay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.8,0,http://www.openphacts.org/units/Nanomolar,1557678,=,1,1,=,,IC50,nM,,1600.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,IC50,uM,UO_0000065,,1.6
26936,26936,,,7941070,[],CHEMBL1921197,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,=,1,1,=,,MIC,nM,,970.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.97
26937,26937,,,7941099,[],CHEMBL1921197,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1557678,=,1,0,=,,MBC,uM,,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM,UO_0000064,,1.9
26938,26938,,,7941127,[],CHEMBL1921198,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,=,1,1,=,,MIC,nM,,480.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.48
26939,26939,,,7941151,[],CHEMBL1921198,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1557678,=,1,0,=,,MBC,uM,,0.97,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM,UO_0000064,,0.97
26940,26940,,,7941488,[],CHEMBL1921199,Antimicrobial activity against multidrug-resistant Staphylococcus aureus isolate 1 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,=,1,1,=,,MIC,nM,,31200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,31.2
26941,26941,,,7941517,[],CHEMBL1921199,Antimicrobial activity against multidrug-resistant Staphylococcus aureus isolate 1 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1557678,=,1,0,=,,MBC,uM,,62.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM,UO_0000064,,62.5
26942,26942,,,7941546,[],CHEMBL1921200,Antimicrobial activity against multidrug-resistant Staphylococcus aureus isolate 2 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1557678,=,1,1,=,,MIC,nM,,31200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,31.2
26943,26943,,,7941575,[],CHEMBL1921200,Antimicrobial activity against multidrug-resistant Staphylococcus aureus isolate 2 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1557678,=,1,0,=,,MBC,uM,,31.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM,UO_0000064,,31.2
26944,26944,,,7941612,[],CHEMBL1921267,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 10 uM after 6 days by MTT colorimetric microassay,F,,,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1557678,=,1,0,=,,GI,%,,98.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,GI,%,UO_0000187,,98.0
26945,26945,,,7941649,[],CHEMBL1921268,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 1 uM after 6 days by MTT colorimetric microassay,F,,,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1557678,=,1,0,=,,GI,%,,95.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,GI,%,UO_0000187,,95.0
26946,26946,,Not Active,7941662,[],CHEMBL1921269,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 0.1 uM after 6 days by MTT colorimetric microassay,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1914411,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1557678,,1,0,,,GI,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,GI,,,,
26947,26947,,Not Determined,7945018,[],CHEMBL1924263,Antimicrobial activity against Candida albicans ATCC 90028 by CLSI method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,IC50,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,IC50,,,,
26948,26948,,Not Determined,7945019,[],CHEMBL1924263,Antimicrobial activity against Candida albicans ATCC 90028 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
26949,26949,,Not Determined,7945020,[],CHEMBL1924263,Antimicrobial activity against Candida albicans ATCC 90028 by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,MFC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MFC,,,,
26950,26950,,Not Determined,7945021,[],CHEMBL1924264,Antimicrobial activity against Cryptococcus neoformans ATCC 90113 by CLSI method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,IC50,,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,IC50,,,,
26951,26951,,Not Determined,7945022,[],CHEMBL1924264,Antimicrobial activity against Cryptococcus neoformans ATCC 90113 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,MIC,,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,,,,
26952,26952,,Not Determined,7945023,[],CHEMBL1924264,Antimicrobial activity against Cryptococcus neoformans ATCC 90113 by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,MFC,,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MFC,,,,
26953,26953,,Not Determined,7945024,[],CHEMBL1924265,Antimicrobial activity against Aspergillus fumigatus ATCC 90906 by CLSI method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,IC50,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,IC50,,,,
26954,26954,,Not Determined,7945025,[],CHEMBL1924265,Antimicrobial activity against Aspergillus fumigatus ATCC 90906 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,MIC,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC,,,,
26955,26955,,Not Determined,7945026,[],CHEMBL1924265,Antimicrobial activity against Aspergillus fumigatus ATCC 90906 by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1562999,,1,0,,,MFC,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MFC,,,,
26956,26956,,,7945027,[],CHEMBL1925378,Antimicrobial activity against Mycobacterium intracellular ATCC 23068 after 5 days by MABA assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.38,0,http://www.openphacts.org/units/Nanomolar,1562999,=,1,1,=,,IC50,nM,,420.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,uM,UO_0000065,,0.42
26957,26957,,,7945028,[],CHEMBL1925378,Antimicrobial activity against Mycobacterium intracellular ATCC 23068 after 5 days by MABA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1562999,=,1,1,=,,MIC,nM,,1000.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,uM,UO_0000065,,1.0
26958,26958,,,7945029,[],CHEMBL1925378,Antimicrobial activity against Mycobacterium intracellular ATCC 23068 after 5 days by MABA assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921722,Bioorg Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,1562999,>,1,0,>,,MBC,uM,,1.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MBC,uM,UO_0000064,,1.0
26959,26959,,,7947090,[],CHEMBL1926014,Antibacterial activity against Bacillus cereus ATCC 11778,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921755,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563047,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.08
26960,26960,,,7947113,[],CHEMBL1926015,Antibacterial activity against Staphylococcus aureus ATCC 2587,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921755,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563047,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.25
26961,26961,,,7947136,[],CHEMBL1926016,Antibacterial activity against Escherichia coli ATCC 8739,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921755,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563047,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
26962,26962,,,7947159,[],CHEMBL1926017,Antibacterial activity against Moraxella catarrhalis ATCC 232446,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921755,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563047,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,1.25
26963,26963,,,7948214,[],CHEMBL1924461,Antibacterial activity against Shigella dysenteriae assessed as zone of growth inhibition at after 18 to 24 hrs by Kirby-Bauer agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1561099,=,1,1,=,,IZ,mm,,14.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,DIZ,mm,UO_0000016,,14.0
26964,26964,,,7948215,[],CHEMBL1924460,Antibacterial activity against Vibrio cholerae MTCC 3904 assessed as zone of growth inhibition after 18 to 24 hrs by Kirby-Bauer agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1561099,=,1,1,=,,IZ,mm,,24.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,DIZ,mm,UO_0000016,,24.0
26965,26965,,,7948216,[],CHEMBL1924459,Antibacterial activity against Escherichia coli MTCC 1610 assessed as zone of growth inhibition after 18 to 24 hrs by Kirby-Bauer agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1561099,=,1,1,=,,IZ,mm,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,32.0
26966,26966,,,7948299,[],CHEMBL1924462,Antibacterial activity against Staphylococcus aureus MTCC 3160 assessed as zone of growth inhibition after 18 to 24 hrs by Kirby-Bauer agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1561099,=,1,1,=,,IZ,mm,,15.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,15.0
26967,26967,,,7948300,[],CHEMBL1924463,Antibacterial activity against Bacillus cereus MTCC 430 assessed as zone of growth inhibition after 18 to 24 hrs by Kirby-Bauer agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1561099,=,1,1,=,,IZ,mm,,14.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,DIZ,mm,UO_0000016,,14.0
26968,26968,,,7948301,[],CHEMBL1924466,Bactericidal activity against Bacillus cereus MTCC 430 assessed as time required to complete extermination of bacteria by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1561099,=,1,1,=,,TIME,hr,,48.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,Time,hr,UO_0000032,,48.0
26969,26969,,,7948302,[],CHEMBL1924467,Bactericidal activity against Staphylococcus aureus MTCC 3160 assessed as time required to complete extermination of bacteria by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1561099,=,1,1,=,,TIME,hr,,48.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,48.0
26970,26970,,,7948303,[],CHEMBL1924247,Bactericidal activity against Vibrio cholerae MTCC 3904 assessed as time required to complete extermination of bacteria by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1561099,=,1,1,=,,TIME,hr,,48.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,Time,hr,UO_0000032,,48.0
26971,26971,,,7948304,[],CHEMBL1924465,Bactericidal activity against Escherichia coli MTCC 1610 up to assessed as time required to complete extermination of bacteria by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1561099,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
26972,26972,,,7948305,[],CHEMBL1924464,Bactericidal activity against Shigella dysenteriae assessed as time required to complete extermination of bacteria by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921785,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1561099,<,1,1,<,,TIME,hr,,72.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,Time,hr,UO_0000032,,72.0
26973,26973,,,7952116,[],CHEMBL1926350,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921682,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1562243,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
26974,26974,,,7952131,[],CHEMBL1926349,Antibacterial activity against Escherichia coli NCIM 5051 by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921682,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1562243,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
26975,26975,,,7952146,[],CHEMBL1924198,Antibacterial activity against Bacillus subtilis NCIM 2439 by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921682,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1562243,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,4.0
26976,26976,,,7952161,[],CHEMBL1924197,Antibacterial activity against Staphylococcus aureus NCIM 2079 by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1921682,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1562243,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
26977,26977,,,7965318,[],CHEMBL1929826,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 at 10 ug/mL after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1563751,=,1,1,=,,IZ,mm,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,8.0
26978,26978,,,7965331,[],CHEMBL1929827,Antibacterial activity against Escherichia coli ATCC 35218 at 10 ug/mL after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1563751,=,1,1,=,,IZ,mm,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,9.0
26979,26979,,,7965344,[],CHEMBL1929828,Antibacterial activity against Salmonella typhi ATCC 6539 at 10 ug/mL after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1563751,=,1,1,=,,IZ,mm,,39.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,IZ,mm,UO_0000016,,39.0
26980,26980,,,7965357,[],CHEMBL1930014,Antibacterial activity against Staphylococcus aureus ATCC 6538 at 10 ug/mL after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1563751,=,1,1,=,,IZ,mm,,17.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,17.0
26981,26981,,,7966562,[],CHEMBL1930015,Antibacterial activity against Bacillus subtilis ATCC 6631 at 10 ug/mL after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1563751,=,1,1,=,,IZ,mm,,9.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,9.0
26982,26982,,,7966575,[],CHEMBL1930016,Antibacterial activity against Bacillus sphaericus ATCC 7031 at 10 ug/mL after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,1563751,=,1,1,=,,IZ,mm,,24.0,CHEMBL613863,Lysinibacillus sphaericus,Lysinibacillus sphaericus,1421.0,,,IZ,mm,UO_0000016,,24.0
26983,26983,,,7966588,[],CHEMBL1930017,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 by twofold serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563751,=,1,0,=,,MIC99,ug ml-1,,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC99,ug ml-1,UO_0000274,,12.5
26984,26984,,,7966601,[],CHEMBL1930018,Antibacterial activity against Escherichia coli ATCC 35218 by twofold serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563751,=,1,0,=,,MIC99,ug ml-1,,18.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC99,ug ml-1,UO_0000274,,18.0
26985,26985,,,7966614,[],CHEMBL1930019,Antibacterial activity against Salmonella typhi ATCC 6539 by twofold serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563751,=,1,0,=,,MIC99,ug ml-1,,50.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC99,ug ml-1,UO_0000274,,50.0
26986,26986,,,7966627,[],CHEMBL1930020,Antibacterial activity against Staphylococcus aureus ATCC 6538 by twofold serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563751,=,1,0,=,,MIC99,ug ml-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC99,ug ml-1,UO_0000274,,25.0
26987,26987,,,7966640,[],CHEMBL1930021,Antibacterial activity against Bacillus subtilis ATCC 6631 by twofold serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563751,=,1,0,=,,MIC99,ug ml-1,,25.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC99,ug ml-1,UO_0000274,,25.0
26988,26988,,,7966653,[],CHEMBL1930022,Antibacterial activity against Bacillus sphaericus ATCC 7031 by twofold serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926636,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563751,=,1,0,=,,MIC99,ug ml-1,,20.0,CHEMBL613863,Lysinibacillus sphaericus,Lysinibacillus sphaericus,1421.0,,,MIC99,ug ml-1,UO_0000274,,20.0
26989,26989,,,7975698,[],CHEMBL1929933,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
26990,26990,,,7975699,[],CHEMBL1929934,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
26991,26991,,,7975700,[],CHEMBL1929935,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
26992,26992,,,7975701,[],CHEMBL1929936,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
26993,26993,,,7975702,[],CHEMBL1929937,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
26994,26994,,,7975703,[],CHEMBL1929938,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
26995,26995,,,7975704,[],CHEMBL1931190,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
26996,26996,,,7975705,[],CHEMBL1931191,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
26997,26997,,,7975706,[],CHEMBL1931192,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
26998,26998,,,7975707,[],CHEMBL1931193,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-5 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
26999,26999,,,7975708,[],CHEMBL1931194,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-6 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563532,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
